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Differential Coupling of RGS3s and RGS4 to GPCR-GIRK 
Channel Signaling Complexes 
 
Cristina Jaén 
 
ABSTRACT 
 
 ‘Regulators of G protein signaling’ (RGS proteins) modulate the G protein 
cycle by enhancing the GTPase activity of Gα subunits. These changes 
accelerate the kinetics of ion channel modulation by Gαi/o-coupled receptors 
(GPCRs) such as the G protein-gated inward rectifier K+ (GIRK/Kir3) channel. My 
experiments indicate that a single cerebellar granule (CG) neuron, a cell type that 
endogenously expresses GIRK channels is able to express a wide variety of 
RGS proteins. I selected two of them, which are widely expressed and 
transcriptionally regulated during pathophysiologic conditions, to compare their 
functional properties. I originally described the differential modulatory effects of 
two RGS proteins, the RGS3 short isoform (RGS3s) and RGS4, on muscarinic 
m2 and serotonin 1A receptor-coupled Kir3.1/Kir3.2a channels expressed in 
Chinese hamster ovary (CHO-K1) cells. Both RGS3s and RGS4 accelerated 
GIRK activation and deactivation current kinetics in a similar way. However, only 
RGS3s significantly decreased the maximal GIRK current (Imax) elicited by ACh 
 viii 
(~45% inhibition) and significantly increased the EC50 for both GPCRs. The 
hypothesis that emerged from this initial study was that the distinct RGS4 N-
terminal domain mediated a direct coupling of RGS4 to GPCR-GIRK channel 
signaling complexes that was not shared by RGS3s. To test this hypothesis, I 
epitope-tagged several GPCRs, the Kir3.1 subunit, RGS3s, RGS4, and several 
deletion mutants and chimeras for co-immunoprecipitation experiments. Using an 
epitope-tagged degradation resistant RGS4 mutant RGS4(C2V), I detected co-
precipitation of different GPCR-GIRK channel complexes with RGS4 but not 
RGS3s. 
The functional impact of RGS4 coupling to the GPCR-Kir3 channel 
complex versus uncoupled RGS3s was not apparent in recordings from CHO-K1 
cells presumably due to a high degree of RGS collision-coupling. Controlled 
expression in Xenopus oocytes revealed a 30-fold greater potency for RGS4 in 
the accelerating GIRK channel gating kinetics. 
In summary, these findings demonstrate that one of the ways for the cell 
to achieve signaling pathway specificity may be through selective coupling of the 
different GPCR-effector-RGS protein complexes. 
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CHAPTER 1 
INTRODUCTION AND BACKGROUND 
 
G protein coupled receptors (GPCRS) 
G-protein coupled receptors (GPCRs) are transmembrane receptors that 
mediate most of their intracellular actions through pathways involving activation 
of G-proteins. GPCRs have an extracellular N terminus, a cytoplasmic C 
terminus and 7 transmembrane α−helices connected by three intracellular loops 
and three extracellular loops. They are also called heptahelical receptors or 
serpentine receptors. The extracellular receptor surface is critical for ligand 
binding and the intracellular surface is involved in G-protein recognition and 
activation (Wess, 1997). GPCRs are  some of the oldest receptors devoted to 
signal transduction present throughout the evolutionary process, they appear in 
plants, yeast, slime mold, protozoa, diploblastic metazoa as well as vertebrates 
(Bockaert and Pin, 1999).The superfamily of GPCR is the largest gene family 
found so far, more than 1000 human genes have been identified for GPCRs, 
which include the m2 muscarinic receptor, the serotonin 1A receptor, the α2 
adrenergic receptor, the D2-dopaminergic receptor, the opioid receptors, the A1 
adenosine receptor, the lysophosphatidic acid 1 receptor, and the gamma-
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aminobutyric acid type B (GABAB) receptor. GPCRs have a wide variety of 
ligands such as small biogenic amines (for example, 5-hydroxytryptamine (5-HT), 
dopamine, acetylcholine, epinephrine/norepinephrine, histamine), hormones, 
chemokines, local mediators, the amino acid L-glutamate,  peptides, 
polypeptides, nucleotides, prostanoids, calcium ions, and lipids. GPCRs also play 
fundamental roles in sensory systems mediating vision, smell, and taste by 
responding to light, odorants, and taste stimuli (Wess, 1998). It has been 
estimated that about 80% of known hormones and neurotransmitters activate 
cellular signal transduction mechanisms through GPCRs (Birnbaumer 1990), and 
GPCRs represent 30-45% of current drug targets (Drews et al., 2000; Hopkins 
and Groom, 2002). GPCRs are susceptible to post-translational modifications, 
they can be palmitoylated, phosphorylated, and glycosylated. All of these 
modifications are important for the proper channel function, mediating trafficking, 
desensitization, and coupling (Daaka et al., 1997; Duvernay et al., 2005; Qanbar 
and Bouvier, 2003). 
GPCRs show selective coupling to G-proteins, for example, muscarinic 
m1,  m3, and m5 couple to the Gq/G11 family of G-proteins whereas m2 and m4 
subtypes preferentially interact with the Gi/o family (Gainetdinov and Caron, 
1999; Offermanns et al., 1994). Recent studies are challenging the classical idea 
that GPCRs act as monomers, and the stoichiometry is one receptor and one G 
protein coupling. Now it seems that a stoichiometry of 2 GPCRS and 1 G protein 
is more correct (Bulenger et al., 2005). Not only homo-heteromerization of 
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GPCRs is important and necessary for receptor trafficking and maturation, but it 
seems to be important for receptor selectivity as well. Chemokine receptors can 
form homo- and heterodimers. Depending on their composition they activate 
either Gi signaling pathway (homodimers) or Gq/11 (heterodimers) (Mellado et 
al., 2001). The diversity and physiological importance of GPCRs are increasing 
due to splice isoforms from already characterized GPCRs that show differential 
tissue specificity  (Cole and Schindler, 2000; Huang et al., 2004; Mohler et al., 
2001; Zhang et al., 2004).  
 
Guanine nucleotide-binding proteins (G proteins) 
Heterotrimeric guanine nucleotide-binding proteins (G proteins) are 
composed of α, β and γ subunits. They transduce extracellular signals received 
by 7-transmembrane receptors into intracellular signals through effector 
activation (Neer, 1995). Upon GPCR activation, the α subunit of the G protein 
exchanges its bound GDP for GTP. This causes the βγ subunit to dissociate from 
the Gα−GTP subunit, and either Gα−GTP or Gβγ or both act as downstream 
effectors in enhancing the receptor-mediated signal. The duration of G-protein 
coupled signaling is controlled by the lifetime of GTP-bound Gα subunit. 
Termination of the G protein cycle occurs when the intrinsic GTPase activity of 
the Gα subunit hydrolyzes the GTP and Gα-GDP reassociates with its Gβγ 
subunit (Sadja et al., 2003).  Mammalian genes for 16 Gα, 5Gβ, and 12 Gγ 
subunits have been identified, as well as many splice variants for these genes 
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(Downes and Gautam, 1999). G proteins are divided into four families based on 
their Gα subunit: Gs, Gi/o, Gq/11 and G12/13. The Gi/o group is composed of three 
distinct αi (αi1, αi2 and αi3), two splice forms of αo (αoA and αoB), two splice forms 
of αt, αgust and αz (Wess, 1998). The different Gα subunits are determinant for 
receptor coupling specificity. For example serotonin 1A, 1B, and muscarinic m2 
receptors can couple with Gi1 but not Gt, meanwhile adenosine A1 receptor can 
couple to both of them (Slessareva et al., 2003). 
The Gs subunit stimulates adenylyl cyclase (AC) increasing the 
intracellular concentration of cyclic adenosine-3’,5’-monophosphate (cAMP). Gq 
subunit activates phospholipase C-β (PLC-β) catalyzing hydrolysis of the 
phosphatidylinositol 4,5-bisphosphate (PIP2) to form second messengers, inositol 
1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). The Gi/o subunits have 
several functions: Gt1 activates cGMP phosphodiesterase, Go modulates Ca2+ 
channel function, and Gi subtypes inhibits AC (Cabrera-Vera et al., 2003). 
Initially, Gβγ subunits were thought to be as passive elements just binding 
to Gα subunits. Now it is known that Gβγ regulate several effectors such as K+ 
and Ca2+ channels, PLCβs, and PI3 kinase (Cabrera-Vera et al., 2003).  
 
Regulator of G protein signaling (RGS) proteins 
Regulators of G protein signaling (RGS) proteins speed up passage 
through the G-protein cycle by increasing the intrinsic GTPase activity of Gα 
subunits, thereby accelerating the reassociation of the ‘inactive ’heterotrimeric 
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complex Gα(GDP)βγ (Ross and Wilkie, 2000). RGS proteins are characterized by a 
highly conserved ‘RGS domain ’of ~ 125 a.a. that confers direct binding to 
Gα subunits and is flanked by less conserved N- and C-terminal domains of 
variable length (Tesmer et al., 1997). The first mammalian RGS proteins were 
reported about ten years ago (Druey et al., 1996; Vries et al., 1995). More than 
20 mammalian RGS genes have been identified to date and are classified into 
six subfamilies (RZ, R4, R7, R12, RA, RL) based on sequence homology within 
the RGS domain (Hollinger and Hepler, 2002; Ross and Wilkie, 2000).  
Alternative splice isoforms from the already characterized RGS proteins 
have been described, some of them having specific functions (Hollinger and 
Hepler, 2002). Thus far, there are four RGS3 splice isoforms that differ in their N-
terminal domain: C2PA-RGS3, the largest one (Kehrl et al., 2002). PDZ-RGS3, 
that binds through the PDZ domain to the Ephrin B receptor and through the 
RGS domain regulates the migration response of cerebellar granule cells 
mediated by SDF-1 chemoattractant (Lu et al., 2001). RGS3T is a truncated form 
of RGS3, it is localized at the nuclear level and is involved in apoptosis (Dulin et 
al., 2000). And RGS3s “short” is highly expressed in heart, brain and lungs, and 
inhibits chemotactic responses of B lymphocytes (Reif and Cyster, 2000). 
RGS proteins show distinct tissue distribution (Gold et al., 1997; Grafstein-
Dunn et al., 2001), they also have specificity towards Gα subunits. For example 
RGS9 interacts with Gt, meanwhile RGS4 interacts with Gi/o and Gq. RGS2 
interacts preferentially with Gq (Hollinger and Hepler, 2002). 
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RGS proteins can be phosphorylated and palmitoylated, these 
posttranslational modifications produce a variety of effects including alterations in 
subcellular localization, protein stability and alterations in GAP activity (Riddle et 
al., 2005) 
Originally RGS proteins were thought to be only GTPase-activating 
(GAPs) proteins. However, increasing evidence is pointing to a bigger role in 
signal transduction. Some RGS are able to interact with other proteins via non-
RGS domains, such as RGS12 that with the PDZ domain binds to IL-8 receptor 
and through its PTB domain is able to bind to N-type Ca2+ channels. PDZ-RGS3s 
binds via the PDZ domain the Eprin B receptor. RGS3 and RGS7 can bind 14-3-
3 proteins when phosphorylated (Hollinger and Hepler, 2002). RGS4 appears to 
regulate Gα function based in recognition of receptors rather than association 
with Gα. In pancreatic acinar cells carbachol, bombesin, and cholecystokinin 
(CCK) activate Gq/11 pathways via specific GPCRs. Deletion of the RGS4 N-
terminus eliminated the receptor selectivity and reduced the potency of the 
inhibition (Zeng et al., 1998). In another study, RGS1 and RGS16 also displayed 
receptor selectivity, whereas RGS2 displayed no preference among the three 
receptors (Xu et al., 1999). In striatum, RGS9-2 modulates Ca2+ channel 
inhibition in a GPCR specific manner (Cabrera-Vera et al., 2004). 
RGS proteins are emerging as attractive therapeutic targets (Hollinger and 
Hepler, 2002; Neubig and Siderovski, 2002; Riddle et al., 2005; Zhong and 
Neubig, 2001). RGS2 appears to be linked to cardiovascular diseases. RGS2 
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knockout mice exhibit a severe cardiovascular phenotype (Heximer et al., 2003), 
and overexpresion of RGS2 is seen in individuals with Bartter’s/Gitelman’s 
Syndrome (Calo et al., 2004). RGS4 has been linked to schizophrenia (Chowdari 
et al., 2002; Mirnics et al., 2001). In addition, an RGS9 mutation has been 
identified as the cause of a pathological condition, where patients with mutations 
in either RGS9-1 or R9AP (RGS9 anchor protein) have slow photoreceptor 
deactivation and difficulty in adjusting to changes in light levels, as well as in 
seeing low-contrast moving objects (Nishiguchi et al., 2004). 
 
G protein coupled inward rectifying potassium (GIRK) channel 
G protein-gated inward rectifying potassium (GIRK) are selective K+ ion 
channels “opened” by a direct interaction with Gβγ subunits (Logothetis et al., 
1987). GIRK channels belong to the K+ inward rectifier (Kir) channel family, that 
is divided into 6 main subfamilies (Kir1.0-kir6.0), so they can also be named Kir3 
channels (Doupnik et al., 1995). This family is characterized for having “inward 
rectification” which means that these channels allow potassium ions to flow 
through them more readily into the cell than out of the cell at hyperpolarized 
membrane potentials (Hille, 2001). GIRK channels are activated by GPCRs that 
couple to Gαi/o (Dascal, 1997) and inhibited by receptors that couple to Gαq (Lei 
et al., 2001). A large number of agonists can activate GIRK channels through 
Gi/o receptors such as acetylcholine (Dascal et al., 1993), adenosine (Leaney 
and Tinker, 2000), dopamine (Inanobe et al., 1999; Leaney and Tinker, 2000), 
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GABA (Leaney and Tinker, 2000), serotonin (Dascal et al., 1993; Karschin et al., 
1991), norepinephrine (Lim et al., 1995; Mullner et al., 2000), somatostatin 
(Takano et al., 1997), and LPA (Itzhaki Van-Ham et al., 2004) The activation of 
these channels by PTX-sensitive G protein coupled receptors cause membrane 
hyperpolarization. The physiological role of GIRK channels is to maintain the 
resting membrane potential near the potassium equilibrium potential, and to slow 
pacemaker action potential frequency and heart rate (Breitwieser and Szabo, 
1985; Kurachi et al., 1986; Logothetis et al., 1987; Pfaffinger et al., 1985). They 
are also involved in the slow phase of inhibitory postsynaptic potentials (Doupnik 
et al., 1995; Luscher et al., 1997; Nichols and Lopatin, 1997; Stanfield et al., 
2002). The sequestration of Gβγ by GDP-bound Gα subunit will close the 
channel. The kinetics of activation and deactivation of GIRK channels therefore 
reflect the kinetics of the G protein cycle. 
The properties of GIRK channel gating can be modulated by a variety of 
factors such as phosphatidylinositol-4,-5-biphosphate (PIP2), Na+, Mg2+, 
oxidation-reduction, phosphorylation, and acidification (Sadja et al., 2003). 
Four GIRK subunits have been found in mammals (GIRK1,2,3,4 or 
Kir3.1,2,3,4), another subunit GIRK5 has been characterized in Xenopus oocytes 
(Yamada et al., 1998). Furthermore, Kir3.2 has at least three different isoforms 
generated by alternative splicing named Kir3.2a, Kir3.2b, and Kir3.2c (Wei et al., 
1998). Each GIRK subunit has intracellular N and C termini, two transmembrane 
domains and one “P-loop” that is considered the K+ channel “signature 
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sequence” (Hille, 2001). Functional GIRK channels are heterotetramers. 
Neuronal GIRK channels are composed of Kir3.1, Kir3.2, Kir3.3 subunits, 
whereas cardiac channels are formed by Kir3.1 and Kir3.4 subunits. GIRK1/2 
was found to be the dominant heterotetramer mainly detected in brain (Kofuji et 
al., 1995; Liao et al., 1996). Only GIRK1 and GIRK4 subunits are distributed in 
atrial and sinoatrial node cells of the heart (Krapivinsky et al., 1995a), which are 
involved in the regulation of heart rate (Mark and Herlitze, 2000).  
 
Coupling of GPCRs to G proteins and GIRK channels 
This cartoon depicts the signaling pathway that couples GPCRs with GIRK 
channels. 
 
Upon GPCR activation, the αi/o subunit of the G protein exchanges its 
bound GDP for GTP. This causes the βγ subunit to dissociate from the Gα−GTP 
subunit, and bind to the GIRK channel, opening the channel and allowing K+ to 
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flow out of the cell and hyperpolarizing the membrane potential. The duration of 
G protein coupled signaling is controlled by the lifetime of GTP-bound Gα 
subunit. Termination of the G protein cycle occurs when the intrinsic GTPase 
activity of the Gα subunit hydrolyzes the GTP, and Gα-GDP reassociates with its 
Gβγ subunit. RGS proteins speed up the termination of the G protein signal by 
enhancing the intrinsic GTPase activity of the Gαi/o subunit, therefore accelerating 
the closing of the GIRK channel. 
Based on functional findings, a model that postulated the assembly of m2, 
RGS4, G protein and GIRK channel was proposed (Doupnik et al., 1997; Zhang 
et al., 2002). Recently, it has been shown that several GPCRs such as dopamine 
2, dopamine 4 and beta2 adrenergic receptors form stable complexes with Kir3 
channels in COS-7 and HEK 293 cells and brain tissue (Lavine et al., 2002). 
Some in vitro experiments indicate that RGS2 is able to bind to the third 
intracellular loop of the Gq/11-coupled m1 muscarinic receptor (Bernstein et al., 
2004). 
My work described here confirms the existence of these supracomplexes 
composed of GPCR-G protein-RGS4-GIRK channels, indicating that indeed RGS 
proteins are more than simply GAPs and serve as anchoring proteins in the 
assembly of these signaling complexes. 
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CHAPTER 2 
GENERAL METHODS AND MATERIALS 
 
Cerebellar granule neuron cultures 
Cerebellar granule (CG) neurons from neonatal rat pups were both 
amiable to enzymatic isolation and primary culture for experimental 
manipulations. To isolate and culture postnatal day 4–6 rat CG neurons, I used a 
protocol modified from (Slesinger and Lansman, 1991). Following ip injection of 
sodium pentobarbital (4 mg/100 g body weight) to induce deep anesthesia, rat 
pup cerebella (2–4) were removed rapidly and placed in a 35-mm culture dish 
containing ice-cold calcium and magnesium-free (CMF) Tyrode’s solution (in 
mM): 136.9 NaCl, 5.4 KCl, 6.0 NaHCO3 , 0.33 Na2HPO4 , 5.5 D-glucose, 5.0 
HEPES, at pH 7.4 (NaOH), containing 100 U/ml penicillin and 0.1 mg/ml 
streptomycin. The tissue was minced, washed with CMF Tyrode’s solution, and 
then digested with 0.5 ml of trypsin/EDTA solution (GIBCO 25300-054) for 10 
min at room temperature. The digestion was stopped by placing on ice and 
adding ‘‘isolation medium’’ that consisted of modified Eagle’s medium with 
Earle’s salts (GIBCO 11095-080) supplemented with 10% heat-inactivated horse 
serum, 25 mM KCl, 6 mg/ml d-glucose, 2 mM glutamine, 0.5 U/ml DNase I, 0.5 
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U/ml penicillin, and 0.5 g/ml streptomycin. The digested tissue was then triturated 
using a 1-ml sterile pipette, and the dispersed cells plated at low density on poly-
l-lysine-coated 35-mm Corning cell culture dishes. The cells were incubated for 5 
h at 37o in a 5% CO2 atmosphere, and then the culture medium was changed to 
serum-free Neurobasal-A medium (GIBCO 10888-022) with B-27 supplement 
and 25 mM KCl, 2 mM glutamine, 0.5 U/ml penicillin, and 0.5 g/ml streptomycin. 
The cerebellar cell cultures were then maintained in a humidified incubator at 37o 
with a 5% CO2 atmosphere for 24–48 h before extensive neurite outgrowth took 
place. All procedures for the use and handling of rats were approved by our 
institutional animal care and used in accordance with NIH guidelines. 
 
Single cell harvesting for RT-PCR analysis 
Single rat CG neurons were harvested from culture dishes using a 
micropipette (15–30 µm tip diameter) fabricated from borosilicate glass tubes (1.5 
mm outside diameter, 0.86 mm inside diameter, GC150F-10, Warner 
Instruments) by a programmable microelectrode puller (P-97, Sutter 
Instruments). Latex gloves were worn throughout the handling and harvesting 
procedure to minimize potential sources of contamination. The micropipette was 
attached to a microelectrode holder used for patch-clamp recordings, allowing 
application of negative or positive pressure via an attached syringe. The culture 
dishes were first washed with a solution consisting of (mM) 145 NaCl, 5 KCl, 2 
CaCl2 , 1 MgCl2 ,10 D-glucose, 5 HEPES, at pH 7.4 (NaOH) at room temperature 
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(~ 23oC). A single CG neuron having bipolar morphology (Fig. 3.1A) was then 
drawn into the micropipette by negative pressure. The micropipettes were not 
filled with solution initially, but contained 5 µl of the external solution after the cell 
had been harvested. The contents of the micropipette were then expelled into a 
PCR tube by positive pressure and the tube was placed on ice. For each 
experiment, four to six single cells were harvested and tested in parallel with 
negative and positive controls. Two negative control samples were a 5 µl sample 
of RNase-free H2O and a 5 µl sample of the external solution. Positive controls 
included poly(A)+ mRNA from neonatal rat whole brain (0.5–5.0 ng). Experiments 
were generally repeated three times from separate dissections/ cultures for each 
RGS examined to account for animal, culture, and cell variability. 
 
Design of intron-spanning gene-specific primers 
The RT-PCR approach utilizes gene-specific primers that selectively 
amplify mRNA transcripts from a specific RGS gene from a single cell. Because 
all mammalian RGS genes are poly-intronic (Sierra et al., 2002), intron-spanning 
primers were designed  to distinguish mRNA-derived PCR products from 
genomic DNA-derived products (Doupnik et al., 2001). At the time of my original 
study, sequence information for rat RGS genes was limiting so mouse and 
human RGS sequences were used as alternatives for primer design. The 
effectiveness of each RGS primer set was confirmed by positive controls using 
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samples of rat brain poly(A) mRNA. A full list of the RGS primer sequences is 
provided (see Table.2.1). 
 
Single cell reverse transcriptase PCR (RT-PCR) analysis 
One-step RT-PCR was carried out using the intron-spanning gene-specific 
primers according to the manufacturer’s protocol (OneStep RT-PCR, Qiagen 
Inc.). For each 5 µl sample, 20 µl of a RT-PCR master mix was added and 
contained the following: forward and reverse primers at 0.6 µM each (final 
concentration), dNTPs at 400 µM each (final concentration), Omni-script and 
Sensiscript reverse transcriptases, HotStar Taq DNApolymerase, RNase 
inhibitor, and a buffer solution containing Tris–Cl, KCl, (NH4)2SO4 , MgCl2 , and 
dithiothreitol. Concentrations of enzymes and buffer components were as 
recommended by the manufacturer (1X concentration, Qiagen, Inc.) and included 
the 1X ‘‘Qsolution,’’ which effectively reduced nonspecific bands produced by 
mispriming events. Each 25 µl sample was then placed in a PCR thermocycler 
(GeneAmp 2400, PE Biosystems, Inc.) for the following temperature protocol: 50o 
for 30 min (reverse transcription), 95o for 15 min (activation of HotStar Taq 
polymerase), 45 cycles of 94o for 30s (melt), 3–4o below the primer annealing 
temperature for 30s, and 72o for 60–90s (extension). At the end of the cycling 
period, samples were held at 72o for 10 min (final extension) and the reaction 
was stopped by cooling to 4o. According to the manufacturer (Qiagen Inc.), this 
PCR cycling protocol (45–50 cycles) was expected to allow detection of mRNA 
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transcripts in the general range of 10 to 100 copies per cell. The PCR samples 
were then analyzed by 2% agarose gel electrophoresis, and the products were 
visualized by ethidium bromide staining and UV illumination. Gel images were 
captured using a digital gel-imaging system (BioImager, Genomic Solutions Inc.) 
and were scored for positive or negative expression based on visual detection of 
the expected gel band.  
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Table 2.1 Gene Specific Primers for Single-Cell RT-PCR 
Genbank Location Annealing Product
cDNA Species Accession # Primer Sequence (ATG = +1) Temp. (oC) Size (bp)
GIRK 2a mouse Forw ard 5' CCTGCCGGGGCTGATGATGTGA 3' 58 339
Reverse 5' TTGGTCCTGTCTCGGCTGATGTGT 3'
RGS 1 human S59049 Forw ard 5' TTGAGTTCTGGCTGGCTTGTG 3' +296 52.6 246
Reverse 5' CTGATTTGAGGAACCTGGGATAA 3' +541
RGS 2 mouse U67187 Forw ard 5' GACCCGTTTGAGCTACTTCTTG 3' +126 54.6 494
Reverse 5' CCGTGGTGATCTGTGGCTTTTTAC 3' +619
RGS 3L human U27655 Forw ard 5' TTCGCCCAGCACCCTCAAGA 3' +894 59.6 473
Reverse 5' ATGCCTGGATCGCGATGTATTCA 3' +1366
RGS 3 human U27655 Forw ard 5' TCCCGGAAGAGAAAGAGCAAAAA 3' +1018 58.0 349
Reverse 5' ATGCCTGGATCGCGATGTATTCA 3' +1366
RGS 4 rat U27767 Forw ard 5' TGCAGGCAACAAAAGAGGTGAA 3' +362 55.5 192
Reverse 5' CCCCGCAGCTGGAAGGAT 3' +553
RGS 5 mouse U67188 Forw ard 5' AGCCGCCAGCCAAAATGTGTA 3' -14 58.3 525
Reverse 5' CAAAGCGGGGCAGAGAATCCT 3' +511
RGS 6 human NM004296 Forw ard 5' GGGGCGGGACCAGTTTCTACGAT 3' +1035 59.1 352
Reverse 5' CCCGCCAGCGACTTTCCCTTCT 3' +1386
RGS 7 rat AB024398 Forw ard 5' ACCCATTTCTTGTACCGCCTGACC 3' +881 57.2 485
Reverse 5' TCTGCCCTTTCTCTTTGCCTGTAG 3' +1365
RGS 8 rat AB006013 Forw ard 5' GACAAACCCAACCGCGCTCTCAAG 3' +106 60.6 288
Reverse 5' CGTGGCCTCTCGGGTCTGGAAATC 3' +393
RGS 9 rat AB019145 Forw ard 5' TACCGGACTGGAAAGGAGAGGAAC 3' +496 58.6 579
Reverse 5' ACCCGGTGCCAGGAACAGC 3' +1074
RGS 10 human NM002925 Forw ard 5' GAGCCTCAAGAGCACAGCCAAATG 3' +48 56.9 278
Reverse 5' GCGGTTCTTCCAGGATCTTCTCGT 3' +325
RGS 11 mouse AF061934* Forw ard 5' TCAGTGCGGAAAACCTCA 3' +890* 56.1 335
Reverse 5' CCGCAAGAATGGAAATG 3' +1224*
RGS 12 rat U92280 Forw ard 5' ATCGAAATGTTAGAAAGACCAAAGAGGAC 3'+1847 59.5 1105
Reverse 5' ATGGAAAACCCGGACTTGACAGCA 3' +2951
RGS 13 human AF030107 Forw ard 5' TCAAACGGATCATAACAAAGAGGA 3' -180 52.7 286
Reverse 5' CAAAAGACTGGGCCCACTGTAATA 3' +106
RGS 14 rat U92279 Forw ard 5' TCAGCGCCGAGAATGTAACTTT 3' +266 57.8 181
Reverse 5' TGGGCCAGCACCTCCTCACTAA 3' +446
RGS 16 mouse U72881 Forw ard 5' TGCCGCACCCTAGCCACCTTC 3' +4 59.3 369
Reverse 5' TTCGCTGCGGATGTACTCGTCAAA 3' +372
RGS 17 mouse AF191555 Forw ard 5' GGAAACCAAAGGCCCAACAATAC 3' +58 57.0 350
(RGSZ2) Reverse 5' ATCATCCTGGCCTTTTCTTCAACA 3' +407
RGS 18 mouse AF302685 Forw ard 5' GCCAAAATCAGAGCGAAAGA 3' +109 53.6 421
Reverse 5' GTGCCGTATCAAAACTGTGGAG 3' +529
RGS 19 rat AF068136 Forw ard 5' ACGGGCCGCAGTGTATTCC 3' +295 57.9 276
(GAIP) Reverse 5' CCGGTGCATGAGGGTGTAGAT 3' +570
RGS 20 mouse NM021374 Forw ard 5' AGAAGACCAGAGACCCCAAAGAGC 3' +231 56.6 434
(RGSZ1) Reverse 5' AGTTCATGAAGCGGGGATAGGAGT 3' +664
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Chinese hamster ovary (CHO-K1) cells for heterologous expression 
Chinese hamster ovary (CHO-k1) cells are a commonly used mammalian 
expression system. CHO-K1 cells are very robust and easy to grow in culture 
conditions, they also display a high cotransfrection efficiency using cationic lipid-
based transfection methods, a critical attribute for reconstituting expression of 
multiple protein within a single cell (Ehrengruber et al., 1998). CHO-K1 cells have 
a round geometry and small size making them well suited for whole-cell patch-
clamp recordings (Doupnik et al., 1997; Ehrengruber et al., 1998; Jaen and 
Doupnik, 2005). CHO-K1 cells do not express endogenous GIRK channel 
subunits, yet they do express various GPCRs (Schonbrunn, 2004) and RGS 
proteins. The endogenous expression of RGS mRNA in CHO-K1 cells has been 
partially characterized (RGS1, RGS2, RGS3, RGS4, RGS10, RGS16, and 
RGS19) with RGS2 being significantly expressed, RGS4 not expressed, and the 
others being expressed at moderate to low levels based on RT-PCR analysis 
(Boutet-Robinet et al., 2003; Takesono et al., 1999). 
 
Heterologous expression of wild type cDNAS in CHO-K1 cells 
CHO-K1 cells (American Type Culture Collection, Manassas, VA) were 
cultured in α-modified Eagle’s medium containing 5% fetal bovine serum and 0.1 
mg/ml streptomycin, and maintained in a humidified 5% CO2 incubator at 37 oC. 
One day after low density plating in 35 mm dishes, cells were transfected with 
DNA-liposome complexes composed of lipofectamine (Invitrogen, Carlsbad, CA) 
 18 
and a mixture of cDNAs cloned into the mammalian expression vector 
pcDNA3.1(+) (Invitrogen). The total DNA (µg) to lipofectamine (µg) ratio was kept 
constant at 1:5 when pre-forming the DNA-liposome complexes. The amount of 
each DNA vector in the mixture per dish was as follows; 0.2 µg rat Kir3.1 
(GenBank accession # NM_031610), 0.2 µg mouse Kir3.2a (GenBank accession 
# NM_010606), 0.2 µg GPCR either human muscarinic m2 receptor (GenBank 
accession # NM_000739) or human 5-HT1A receptor (GenBank accession # 
NM_000524), with or without 1.0 µg RGS either mouse RGS3s (GenBank 
accession # NM_134257) or rat RGS4 (GenBank accession # NM_017214), with 
0.1 µg enhanced green fluorescent protein (GFP) cDNA (pGreenlantern-1, 
GIBCO) included as a reporter gene (Doupnik et al., 1997; Doupnik et al., 2004). 
The transfected cells were incubated overnight in serum-free OPTI-MEM media 
(Invitrogen). Twenty-four to thirty-six hours after transfection, single GFP-positive 
cells were selected for electrophysiological recordings. The RGS3s cDNA clone 
was generously provided by Drs Karin Reif and Jason Cyster (University of 
California, San Francisco) (Reif and Cyster, 2000). All other cDNA clones were 
as described elsewhere (Doupnik et al., 1997; Doupnik et al., 2004). For 
pertussis toxin (PTX) pre-treatment experiments, transfected CHO-K1 cells were 
incubated overnight (12-18 h) with 100 ng/ml PTX (P-7208, Sigma Chemical). 
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Construction of epitope-tagged expression vectors 
N-terminal-tagged GPCR’s - Complimentary DNA’s encoding the human 
muscarinic m2 receptor (Genbank Accession # NM_000739), human serotonin 
1A receptor (Genbank Accession # NM_000524), and mouse lysophosphatidic 
acid (LPA1/edg2) receptor (Genbank Accession # NM_010336) were “tagged” at 
their N-termini with the hemagglutinin (HA) sequence (YPYDVPDYA). The HA 
tag was preceded by a modified influenza hemaglutinin signal sequence 
(MKTIIALSYIFCLVFA) for efficient membrane targeting (Guan et al., 1992). The 
signal sequence and HA tag sequence were introduced by annealing two 
complimentary oligonucleotide primers (Sigma-Genosys) that contained a 5’ Hind 
III restriction site followed by a Kozak translation initiation sequence 
(GCCGCCACC), the 16 a.a. signal sequence, the 9 a.a. HA sequence, and 
finally a 3’ Xba I restriction site. The annealed duplex was then cut with Hind III 
and Xba I, and cloned into the pcDNA3.1(+) mammalian expression vector 
(Invitrogen). The complete coding region of the human muscarinic m2 receptor, 
human serotonin 1A receptor, and mouse LPA1 receptor were then amplified by 
PCR and cloned in-frame at the Xba I site of the N-terminal HA-tag pcDNA3.1(+) 
vector. The cloning process resulted in two additional amino acids (SR) between 
the HA tag and starting methionine of the native GPCR sequence due to the   
Xba I sequence. The human adenosine A1 receptor (Genbank Accession # 
AY136746), human dopamine D2L receptor (Genbank Accession # 
NM_000795), and human muscarinic m1 receptor (Genbank Accession # 
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AF498915) were obtained from the University of Missouri, Rolla cDNA Resource 
Center (www.cdna.org) and contained N-terminal triple (3X) HA tags, and were 
cloned into the pcDNA3.1(+) vector. 
C-terminal-tagged Kir3 channels - The rat Kir3.1 channel subunit 
(Genbank Accession # NM_031610) was tagged at the C-terminus with the MYC 
epitope (EQKLISEEDL) by PCR and cloned into the pBudCE4.1 vector 
(Invitrogen). The pBudCE4.1 vector is a duel expression vector where Kir3.1-
MYC expression was driven by the CMV promoter. Mouse Kir3.2a (Genbank 
Accession # NM_010606) was cloned into the second cloning site with 
expression driven by the EF-1a promoter. The Kir3.2a subunit was not modified 
by epitope tagging. The resulting Kir3.1-MYC/Kir3.2a-pBudCE4.1 construct 
yielded expression of both Kir3 channel subunits from a single DNA plasmid. 
C-terminal-tagged RGS proteins - Rat RGS4 (Genbank Accession # 
NM_017214) and mouse RGS3s (Genbank Accession # NM_134257) were 
tagged at their C-termini with the FLAG epitope (DYKDDDDK) by PCR using 
primers that incorporated the FLAG sequence. The RGS-FLAG constructs were 
cloned into the pBudCE4.1 vector with expression driven by the CMV promoter. 
Enhanced green fluorescent protein, GFP(S65T) (pGreenlantern-1, GIBCO), was 
cloned into the second site with expression driven by the EF-1a promoter. The 
resulting RGS-FLAG/GFP-pBudCE4.1 plasmids provided expression of the RGS-
FLAG protein and the GFP reporter protein from a single DNA plasmid. A 
pBudCE4.1 plasmid containing only GFP(S65T) was also generated for negative 
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control (RGS-) experiments. All point mutations, deletion mutations, and 
chimeras of RGS3s-FLAG and RGS4-FLAG were constructed by PCR and also 
cloned into the CMV promoter driven site of GFP-pBudCE4.1 vector. 
The sequence of all epitope-tagged full-length cDNA constructs were 
confirmed by automated DNA sequencing (Molecular Biology Core Facility, 
Moffitt Cancer Center and Research Institute, Tampa, FL). 
 
Transfection of epitope-tagged cDNAs in CHO-K1 cells 
The transfection was very similar to the one previously described. In this 
case, for electrophysiological experiments, cells were plated at low density on 35 
mm culture dishes, and for biochemical experiments, cells were plated at a 
similar density on 100 mm culture dishes. 
Cells were transfected using lipofectamine (Invitrogen) and a mixture of 3-
4 expression vectors. The total DNA (µg) to lipofectamine (µg) ratio was kept 
constant at 1:5 when pre-forming the DNA-liposome complexes. The amount of 
each DNA vector in the mixture for each 35 mm dish was as follows; HA-GPCR-
pcDNA3.1 (0.2 µg), Kir3.1-MYC/Kir3.2a-pBudCE4.1 (0.2 µg), and either RGS-
FLAG/GFP-pBudCE4.1 or GFP-pBudCE4.1 (negative control) (1.0 µg). For 
transfection of cells plated in 100 mm dishes, the amounts were scaled 8X. 
Transfected CHO-K1 cells were incubated 24-36 hr in serum-free OPTI-MEM 
media (Invitrogen). For some experiments, mammalian expression vectors 
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containing different Gα subunit cDNA’s (Gαi2(C352G), GαoA(C351G), or Gαq) were 
included (1.6 µg for 100 mm dish). 
 
Immunoprecipitation and co-immunoprecipitation 
Transfected CHO-K1 cells (100 mm dishes) were first washed with ice-
cold Tris Buffered Saline (TBS pH 7.2). Three 100 mm plates were combined for 
each experimental condition.  Cells were lysed and collected by cell scraping in 
800 µl of extraction buffer at 4oC. The extraction buffer was composed of 150 
mM NaCl, 50 mM Tris pH 7.5, 1 mM EDTA, 1% n-dodecyl-β-D-maltoside (MP 
Biomedicals), and a protease inhibitor cocktail (Complete Mini EDTA-free, 
Roche). The crude cell lysate was then left end-over-end rotating at 4oC for 30 
minutes to solubilize cell membranes. Afterwards, the sample was spun for 10 
minutes at 14,000 g to remove cellular debris. The protein concentrations of the 
final supernatants (cell lysates) were determined using a BCA assay (Pierce). 
Immunoprecipitations were performed using anti-HA or anti-MYC 
antibodies conjugated to agarose beads (Profound IP/Co-IP kits, Pierce). Briefly, 
cell lysates (~750 µl or ~600 µg) were transferred to spin columns and either 
anti-HA or anti-MYC agarose beads added (10 µg) followed by end-over-end 
rotation for 4 hours at 4oC. The columns were then spun to remove the cell 
lysate, and the beads then washed three times with extraction buffer (500 µl 
each). The immunoprecipitated proteins bound to the agarose beads were then 
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eluted 3X (10 µl each) with pH 2.8 elution buffer (Pierce). The acidic protein 
sample was then immediately neutralized with 1.5 µl of 1M Tris, pH 9.5. 
 
Western blot analysis 
Western blotting was performed using standard methodology. The eluted 
protein samples (~30 µl) were added to 7.5 µl of a 5X SDS loading buffer (0.3 M 
Tris-Cl, pH 6.8, 5% SDS, 50% glycerol, and a lane tracking dye) that also 
contained β-mercaptoethanol (~10%). The samples were heated for 5 minutes at 
95oC. A portion of the denatured protein sample (~20 µl) was then separated by 
gel electrophoresis using 4-15% or 8-16% Tris-HCl glycine polyacrylamide gels 
(BIO-RAD) and transferred to polyvinylidene difluoride (PVDF) membranes 
(Immobilon-P, Millipore). 
PVDF membranes were first incubated for 1 hr in blocking buffer (5% 
nonfat dry milk powder in TBS with 0.05% Tween 20), then incubated overnight 
at 4oC with the appropriate primary antibody; (1:1000) HRP-conjugated anti-HA 
12CA5 antibody (Roche); (1:1000) HRP-conjugated anti-MYC 9E10 antibody 
(Roche); (1:1000) HRP-conjugated anti-FLAG M2 antibody, or 5-10 µg/ml anti-
FLAG M2 antibody (F-3165 Sigma-Aldrich). For anti-FLAG immunodetection 
using the non-HRP conjugated antibody (F-3165), membranes were washed in 
blocking buffer (5X) and subsequently incubated for 1 hour with an HRP-
conjugated goat anti-mouse secondary antibody diluted 1:10,000 in blocking 
buffer (sc-2318 Santa Cruz). Following all antibody incubations, PVDF 
 24 
membranes were washed 4 times (15 minutes each) with TBS containing 0.05% 
Tween 20, followed by 2 times (20 minutes each) with TBS. HRP-
immunoreactive protein bands were then resolved by enhanced 
chemiluminescence (Luminol, Santa Cruz), and detected by exposure to blue-
sensitive autoradiography film (Midwest Scientific). For some PVDF membranes, 
antibodies were stripped and re-probed with a different antibody. 
 
Electrophysiological recordings from cerebellar granule neurons 
Critical to resolving RGS modulated GIRK current kinetics in mammalian 
cells is establishing an electrophysiology setup capable of rapid solution changes 
for agonist application and washout during whole-cell voltage-clamp recording. I 
currently use the SF-77B Fast-Step perfusion system (Warner Instruments) that 
consists of a 3-barrel array made of 700 µm square capillary tubes, delivering 
gravity-driven flow of 3 independent solutions in parallel. Each barrel can receive 
input via a manifold connecting up to six different solution reservoirs to expand 
the solution testing capability. The movement and position of the barrel array is 
computer controlled, having a limiting step-speed of ~240 ms , though can be as 
fast as 120-140 ms at the highest flow rates I can generate (~75 cm column 
height). These solution exchange rates are comparable to some (Breitwieser and 
Szabo, 1988; Bunemann et al., 1996), though somewhat slower than the 10-50 
ms time constants reported by others using similar configurations (Karschin et 
al., 1991; Sodickson and Bean, 1996). Nonetheless, they are sufficient to 
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temporally resolve the GIRK current kinetics observed at room temperature (22-
24oC) with and without RGS co-expression.  Cerebellar granule neurons are 
selected for electrophysiological recordings using standard whole-cell tight-seal 
patch clamp methods (Hamill et al., 1981). Cells are initially washed and placed 
in an external solution that consists of (in mM); NaCl 145, KCl 5, CaCl2 2, MgCl2 
1; glucose 10, HEPES 5 (pH = 7.4). After gigaseal formation and breaking into 
the cell for whole-cell recording, 2 min is allowed to permit equilibration of the 
intracellular solution. The composition of the internal pipette solution is (in mM): 
KCl 120, NaCl 10, MgCl2 5, EGTA 1, HEPES 5, ATP 5, GTP 0.2 (pH= 7.2). First 
after breaking into the cell, the membrane capacitance (a direct measure of cell 
surface area) is determined via amplifier compensation, and later used to 
express the maximal current amplitude as a current density (pA/pF) for cell-to-
cell comparisons. Agonist-evoked inward K+ currents are recorded from a holding 
potential of -100 mV, which is sufficiently negative to the experimentally set K+ 
equilibrium potential (EK = -40 mV). 
Thus after establishing the whole-cell recording and clamping the 
membrane potential to -100 mV, the cell is initially superfused with a “high K+“ 
solution composed of (in mM): NaCl 125, KCl 25, CaCl2 2, MgCl2 1; glucose 10, 
HEPES 5 (pH = 7.4). The solution is applied via one of the 700 µm square 
capillary tubes positioned next to the cell and connected to a 20 ml syringe 
reservoir where the flow rate is gravity controlled by adjusting the syringe height. 
After a stable baseline holding current is established, the agonist is applied (in 
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the high K+ solution) via the step movement of the barrel array so that agonist 
flow via the adjacent barrel is positioned in line with the recorded cell. We 
typically apply the agonist for 15s to minimize receptor desensitization, followed 
by agonist washout with the step movement back to the high K+ solution barrel 
(see Figure 2.1B). Voltage-clamp recordings are performed using an Axoclamp 
1D amplifier (Axon Instruments). Current signals are sampled and digitized via a 
Digidata 1200B A/D board that also synchronizes digital output signals to the SF-
77B Fast-step controller. Axon pCLAMP8.0 software is used to trigger the 
perfusion barrel movements along with 500 ms voltage ramps (- 100 to +50 mV) 
evoked before and during agonist application to assess the voltage-dependent 
properties of the agonist-evoked currents. Characteristic features of GIRK 
currents include steep inward rectification and K+ selectivity (i.e. a reversal 
potential near the EK). The analog current signals are low-pass filtered with the 
amplifier’s integrated 4-pole Bessel filter at a corner frequency of 50 Hz, and then 
digitally sampled at 100 Hz. The time constants for GIRK current activation (τact) 
and deactivation (τdeact) are derived by fitting a single exponential function to the 
rising or decaying portion of the current (Figure 3.1D/E) using non-linear least-
squares curve-fitting software (Clampfit 8.0).  
 
Electrophysiological recordings from CHO-K1 cells 
Electrophysiological recordings from CHO-K1 cells were performed as 
explained for CG granule neurons. In this case, GFP-positive cells were identified 
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by epi-fluorescence microscopy using an inverted microscope (Nikon Diaphot 
with CF N Plan Fluor Ph 20X objective) equipped with a mercury lamp and GFP 
filter set (Endow GFP, Chroma Technology Corp.). Rapid application and 
washout of different agonist (ACh or 5-HT in high K+ solution) concentrations was 
performed using the multi-barrel perfusion system (SF-77B, Warner Instruments) 
(Doupnik et al., 2004), see Figure 2.1A,B 
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Figure 2.1. Whole cell patch-clamp recording of receptor activated GIRK 
currents. (A) CHO-K1 cells twenty-four hours after DNA transfection visualized 
under phase-contrast (upper panel) and epifluorescence (lower panel) 
microscopy. Cells were transfected with EGFP, GIRK channel subunits 
(Kir3.1/Kir3.2a) and the muscarinic m2 receptor. (B) Alignment and movement of 
perfusion barrels for rapid solution exchange. Upper panel shows the three-barrel 
array positioned with the patch clamped cell (see patch electrode) being 
superfused with the high K+ solution (washing solution). Flow through both the 
middle and right barrels is continuous and gravity driven. Lower panel shows the 
position of the barrels following computer-controlled movement (700 µm), where 
the agonist barrel is now aligned with the recorded cell. 
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Electrophysiological recordings from Xenopus oocytes 
All procedures for the use and handling of Xenopus laevis (Xenopus One, 
Ann Arbor, MI) were approved by the University of South Florida Institutional 
Animal Care and Use Committee in accordance with NIH guidelines. Oocytes 
were injected with a mixture of 5’ capped cRNA’s synthesized in vitro from 
linearized cDNA vectors (mMessage mMachine, Ambion). Experimental groups 
(~20 oocytes each) were injected with different cRNA mixtures (50 nl final 
volume) and incubated at 19oC in parallel for 48-60 hrs. All groups received 
cRNA’s for the human muscarinic m2 receptor (0.5 ng/oocyte), rat Kir3.1 subunit 
(0.5 ng/oocyte), and mouse Kir3.2a subunit (0.5 ng/oocyte). Expression of 
RGS4(C2V)-FLAG and RGS3s-FLAG was varied by including different amounts of 
cRNA (0, 0.03, 0.1, 0.3, 1.0, 3.0, 10 ng/oocyte). 
ACh-activated Kir3 channel currents were recorded by two-electrode 
voltage clamp methods from a holding potential of -80 mV (GeneClamp 500, 
Axon Instruments). Oocytes were initially superfused with a minimal salt solution 
(98 mM NaCl, 1 mM MgCl2, and 5 mM HEPES at pH 7.5), then switched to an 
isotonic high K+ solution (20 mM KCl, 78 mM NaCl, 1 mM MgCl2, and 5 mM 
HEPES at pH 7.5) to resolve the kinetics of ACh-activated inward Kir3 channel 
currents. Rapid application and washout of ACh in the high K+ solution was 
performed using a computer triggered superfusion system (SF-77B, Warner 
Instruments)(Doupnik et al., 2004).  To monitor inward rectification of IK,ACh, 
voltage ramps from –80 to +20 mV and 1 s in duration were evoked before and 
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during agonist application. All recordings were performed at room temperature 
(21-23oC). 
 
Kinetic analysis of receptor-activated Kir3 channel currents 
Time-dependent GIRK current kinetics were analyzed using nonlinear 
curve fitting software that fit single exponential functions to derive activation time 
constants (τact) and deactivation time constants (τdeact) (Clampfit 8.0 software, 
Axon Instruments). Agonist dose-response relations were analyzed by fitting 
peak GIRK current amplitudes with the Hill function, where the effective 
concentration producing a 50% response (EC50) and Hill coefficient value (nH) 
were derived from the best fit (Origin 6.0 software, OriginLab Corp.). For 
comparison of GIRK current amplitudes across cells, agonist-evoked currents 
from each cell were normalized to the measured cell membrane capacitance 
(Cm) determined during capacitive current compensation. The normalized current 
amplitudes are expressed as GIRK current density (pA/pF). 
 
Statistical Analysis 
Pairwise statistical analysis between experimental groups was performed 
by one-way ANOVA (analysis of the variance) test where p<0.05 was considered 
significant. 
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CHAPTER 3 
PROFILE OF RGS GENE EXPRESSION IN  
CEREBELLAR GRANULE NEURONS 
 
INTRODUCTION 
 
G-protein-gated inwardly rectifying potassium (GIRK) channels are K+ -
selective ion channels ‘‘opened’’ by a direct interaction with Gβγ subunits 
(Logothetis et al., 1987). Physiologically, GIRK channels play an instrumental 
role in suppressing membrane excitability during the activation of G-protein-
coupled receptors (GPCRs) in neurons, cardiomyocytes, and endocrine cells 
(Stanfield et al., 2002; Yamada et al., 1998). Functional GIRK channels in 
mammals are now known to be heterotetramers composed of Kir3.1, Kir3.2, 
Kir3.3, and Kir3.4 subunits (Stanfield et al., 2002; Yamada et al., 1998). Neuronal 
GIRK channels are more diverse than cardiac GIRK channels, having an 
overlapping expression of Kir3.1, Kir3.2, and Kir3.3 in different regions of the 
brain. Kir3 subunits 1, 2, and 3 are highly expressed in the cerebellum (Karschin 
and Karschin, 1997). Furthemore, they are expressed in the distal part of the CG 
neuron’s dendrites, at the level of the glomeruli where mossy fibers and 
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cerebellar granule (CG) cells synapse (Ponce et al., 1996). It is also known that 
expression of RGS mRNA in brain shows a distinct regional distribution detected 
by in situ hybridization (Gold et al., 1997; Grafstein-Dunn et al., 2001). 
Neuronal GIRK channels have only recently been studied in CG neurons, 
prompted largely from the discovery of the mouse weaver gene that contains a 
point mutation in the Kir3.2 subunit that disrupts K+ selectivity causing CG cell 
death and phenotypic ataxia (Kofuji et al., 1996; Patil et al., 1995; Slesinger et 
al., 1996; Surmeier et al., 1996). The objective of this work is to discern which 
RGS genes are expressed in a CG neuron that are likely to be involved in the 
modulation of endogenous CG neuron’s GIRK channels. 
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RESULTS 
 
Measuring native GIRK channel gating properties in CG neurons. 
Neonatal rat CG neurons exhibited baclofen-evoked GIRK currents that 
were sustained in primary culture and could be characterized 
electrophysiologically (Figure 3.1). GABAB receptor-activated GIRK currents in rat 
CG neurons displayed rapid activation and deactivation kinetics (Figure 3.1F) 
suggesting modulation by endogenous RGS proteins.   
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Fig. 3.1. Quantitative analysis of native GIRK currents recorded from rat 
cerebellar granule (CG) neurons. (A) Phase-contrast image of a typical rat CG 
neuron maintained in primary culture and selected for electrophysiological 
recordings. (B) GABAB receptor agonist baclofen (100 µM) evoke characteristic 
GIRK currents from CG neurons. Baclofen-activated GIRK currents display steep 
inward rectification (C) and rapid activation (D, F) and deactivation kinetics (E, F). 
Data are means ± SEM. Dashed lines in F refer to time constants for solution 
exchange and represent the limit of resolving kinetic events. 
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Single Cell RT-PCR analysis of Endogenous RGS Expression 
To discern which RGS proteins were expressed endogenously in rat CG 
neurons, single cell RT-PCR methods were developed for detecting and profiling 
RGS expression in primary culture neurons. CG neurons were abundant and 
could be distinguished in culture by their relative small size and simple bipolar 
morphology compared to other cells present in the culture dish. Positive Kir3.2 
expression in CG neurons confirmed GIRK channel expression in these cells. A 
great diversity of RGS proteins expressed in the granule neurons was found. In 
some cases, RGS expression was very consistent throughout the different 
dissections, RGS proteins like RGS5, RGS11 and RGS9 were never detected in 
the granule neurons, but others like RGS2, RGS10, RGSz2 and RGS4 were 
almost always detected. However, the detection levels of others like RGS6, 
RGS7 and RGS8 changed greatly from experiment to experiment, making it 
difficult to extrapolate any conclusion (Fig. 3.2). GIRK2a was used as both 
granule neuron marker and control of the efficacy of the sampling method (91% 
efficiency). Results indicated that CG neurons expressed at least 13 different 
RGS genes, and each RGS subfamily (R4, R7, R12, and RZ) was represented 
(Fig 3.3). Although a profile of protein expression was not correlated with mRNA 
data and relative RGS protein levels were unknown, the single cell RT-PCR 
results clearly indicate that numerous RGS proteins are likely to be present in 
these native GIRK-expressing cells. 
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Figure 3.2. Separation of RT-PCR products by agarose gel electrophoresis. RT-
PCR was performed on rat CG neurons as described in the text. Results using 
selected intron-spanning RGS-selective primer sets (Doupnik et al., 2001), as 
well as primer sets for GIRK2 (Kir3.2a) are shown. Negative controls included 
water and external solution (5 µl), and positive controls included postnatal 
poly(A)+ mRNA of brain (0.5–5.0 ng). The predicted molecular size for each RGS 
PCR product is indicated on the right of each gel. 
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Figure 3.3. Profile of RGS expression in rat CG neurons. The percentage of cells 
sampled and positive for RGS expression by RT-PCR analysis is shown for each 
RGS within the R4, R7, R12, and RZ subfamilies examined. The number of cells 
tested for each RGS ranges from 8 to 24 and is from at least two separate 
cultures.  
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DISCUSSION 
 
My results were in agreement with published results obtained by in situ 
hybridization indicating multiple RGS’s are expressed in brain (Gold et al., 1997; 
Grafstein-Dunn et al., 2001). However, my data were obtained from a singular 
type of cell compared to the in situ experiments where the data were obtained 
from a wide variety of tissue. 
I also compared the CG results with the RGS gene profile performed in rat 
atrial myocytes (Doupnik et al., 2001). Both native cell systems expressed RGS 
genes from each RGS subfamily (R4, R7, R12, and RZ). Intestingly, the profile of 
RGS expression in cardiac myocytes and CG neurons had some differences: 
there was more expression of RGS genes in CG neurons, at least 13 compared 
to 7 in myocytes. Also, the percentage of some RGS expression differed 
between the two cell types, for example RGS6 had an expresson of ~95% in 
atrial myocytes in contrast to the ~ 30% in CG neurons. This higher expression of 
RGS genes in CG neurons compared to atrial myocytes also correlated with the 
τdeact of native GIRK channels recorded from both cell types, being faster in the 
CG neurons (Doupnik et al., 2004). 
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My data indicate that CG neurons in culture conditions express 
endogenous and functional GIRK channels and that the fast τdeact observed is 
likely due to the high expression of endogenous RGS. 
My original goal of discerning the unique/s RGS proteins involved in the 
modulation of the GIRK channels clearly was not feasible due to the great variety 
of RGS proteins present in the CG neurons. For this reason, I decided to focus 
my studies on two RGS proteins. I chose RGS3s and RGS4 which were 
expressed in CG neurons and atrial myocytes, and performed the rest of the 
experiments in an heterologous system where I could have better control of the 
components of the signaling pathway. 
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CHAPTER 4 
 
NEURONAL KIR3.1/KIR3.2A CHANNELS COUPLED TO SEROTONIN 1A 
AND MUSCARINIC M2 RECEPTORS ARE DIFFERENTIALLY MODULATED 
BY THE ‘SHORT’ RGS3S ISOFORM 
 
INTRODUCTION 
 
Gβγ-gated inwardly rectifying K+ channels (GIRKs) are expressed 
predominantly in brain, heart, and endocrine tissue and suppress cell excitability 
during neurotransmitter and hormone activation of pertussis toxin (PTX)-sensitive 
G protein-coupled receptors (GPCRs) (Stanfield et al., 2002). Consistent with 
this, gene knockout of neuronal GIRK channel subunits promote spontaneous 
and pharmacologically induced seizures and hyperactivity in mice (Blednov et al., 
2001; Signorini et al., 1997).The recent discovery of neuronal GIRK channel 
involvement in drug-induced analgesia further highlight the physiological role of 
GPCR-activated GIRK channels and their modulators in the nervous system 
(Blednov et al., 2003). 
The temporal gating properties of receptor-activated GIRK currents are 
determined by the kinetic properties of the G protein cycle and dramatically 
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accelerated by ‘regulators of G protein signaling’ (RGSs) (Breitwieser and Szabo, 
1988; Doupnik et al., 1997; Saitoh et al., 1997). RGS proteins speed up passage 
through the G-protein cycle by increasing the intrinsic GTPase activity of Gα 
subunits, thereby accelerating the reassociation of the ‘inactive ’heterotrimeric 
Gα(GDP)βγ complex (Ross and Wilkie, 2000). RGS proteins are characterized by a 
highly conserved ‘RGS domain ’of ~ 125 a.a. that confers direct binding to 
Gα subunits and is flanked by less conserved N- and C-terminal domains of 
variable length (Tesmer et al., 1997). More than 20 mammalian RGS genes have 
been identified to date and are classified into six subfamilies based on sequence 
homology within the RGS domain (Hollinger and Hepler, 2002; Ross and Wilkie, 
2000). 
The divergent amino terminal region of the R4 subfamily of RGS proteins 
has been implicated in (1) mediating RGS selective coupling to GPCRs (Zeng et 
al., 1998), (2) facilitating functional α2 adrenergic receptor-GIRK channel 
coupling in rat sympathetic neurons (Jeong and Ikeda, 2001), and (3) promoting 
translocation of GPCR-RGS complexes to the plasma membrane (Roy et al., 
2003; Saitoh et al., 2002). Thus the divergent RGS amino terminus may provide 
a means to confer selective RGS coupling to different GPCR-effector signaling 
complexes (Hollinger and Hepler, 2002). 
I report here the functional properties of an alternatively spliced ‘short 
isoform’ of mouse RGS3 (RGS3s) (Reif and Cyster, 2000) on neuronal GIRK 
channels (Kir3.1/Kir3.2a) coupled to either serotonin 1A (5-HT1A ) receptors or 
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muscarinic m2 receptors in Chinese hamster ovary cells (CHO-K1). Mammalian 
RGS3 isoforms are expressed in both brain and heart (Druey et al., 1996; Koelle 
and Horvitz, 1996), and alternatively spliced RGS3 transcripts generate at least 
four different protein isoforms having different amino terminal domains that share 
a common RGS domain (Kehrl et al., 2002). The unique amino terminal region of 
mouse RGS3s is 21 amino acids long and comparable in size to the 33 amino 
acid N-terminus of RGS4. Yet RGS3s lacks the two Cysteines (C2 and C12) that 
are conserved in some members of the R4 subfamily including RGS4 and are 
susceptible to plamitoylation (Druey et al., 1999; Hiol et al., 2003; Srinivasa et al., 
1998). I therefore questioned whether the variant RGS3s isoform differentially 
affects GIRK channel gating properties compared to RGS4 (Doupnik et al., 
1997). My findings demonstrate RGS3s differentially modulates GPCR-GIRK 
channel complexes and suggest that different RGS N-termini may influence the 
agonist sensitivity and magnitude of GIRK channel activation in a GPCR-
dependent manner. 
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RESULTS 
 
Properties of 5-HT1A and m2 receptor coupled GIRK currents reconstituted 
in CHO-K1 cells 
Co-expression of neuronal Kir3.1/Kir3.2a channels in CHO-K1 cells with 
either the 5-HT1A receptor or the muscarinic m2 receptor produced agonist-
evoked currents that were dose-dependent and displayed strong inward 
rectification (Fig. 4.1). To resolve the temporal and steady-state kinetic features 
of the receptor-activated GIRK currents, 5-HT and ACh were rapidly applied and 
washed out using concentrations ranging from 10-9 to 10-4 M. The reversal 
potentials for the 5-HT and ACh-evoked currents were both near the 
experimentally preset K+ equilibrium potential (-40 mV) consistent with K+-
selective GIRK channels (Fig. 4.1B). Both the 5-HT-activated GIRK currents (IK,5-
HT) and Ach-activated GIRK currents (IK,ACh) displayed a similar activation and 
deactivation time course following agonist washout (Fig. 4.1A). Notably, however, 
the steady-state dose-dependence of 5-HT versus Ach-activated GIRK currents 
indicated a significantly higher potency for 5-HT versus ACh (Fig. 4.1C). The 
EC50 value for 5-HT was 24±8 nM (n=5) compared to the Ach EC50 value of 
820±162 nM (n=10). This difference in EC50 values indicate either a higher 
 45 
number of 5-HT1A receptors being expressed compared to m2 receptors and/or a 
greater efficacy in 5-HT1A receptor versus m2 receptor signaling. The maximal 
GIRK current density at saturating concentrations of receptor agonist (10 µM) 
was comparable indicating equivalent Kir3.1/Kir3.2a channel expression with the 
two GPCRs; maximal IK,5-HT 90.8±15.4 pA/pF (n=8), maximal IK,ACh 79.2±8.2 
pA/pF (n=11). Other than differences in agonist dose-dependence, the temporal 
kinetic features of IK,5-HT and IK,ACh were indistinguishable.  
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Figure 4.1. Functional coupling of 5-HT1A receptors and muscarinic m2 receptors 
to Kir3.1/Kir3.2a channels expressed in CHO-K1 cells. (A) Representative whole-
cell recordings from two separate cells expressing human 5-HT1A receptors 
(upper trace) or human muscarinic m2 receptors (lower trace). Cells were voltage 
clamped at -100 mV during a 15 s rapid application and washout of receptor 
agonist (10 µM 5-HT or ACh) indicated by the horizontal bars. Voltage ramps 
from -100 to +50 mV were evoked before and during agonist application to 
assess the voltage dependence of the agonist-evoked currents. (B) Inward 
rectification of 5-HT (open circles) and ACh-evoked GIRK currents (filled circles). 
Ramp currents preceding agonist application were digitally subtracted from ramp 
currents evoked during agonist application as shown in (A). Both IK,5-HT and IK,ACh 
displayed strong inward rectification and reversal potentials near the predicted 
Nernst potential for potassium (-40 mV). (C) Dose-response relations for 5-HT 
(open circles) and ACh-activated GIRK currents (filled circles). Receptor-
activated GIRK currents from varying agonist concentrations applied to the same 
cell were normalized to the maximal amplitude recorded from each individual cell. 
Data are the mean±SE from GFP-positive CHO-K1 cells co-transfected with 
cDNA vectors encoding rat Kir3.1, mouse Kir3.2a, and either the human 5-HT1A 
receptor or the human muscarinic m2 receptor, with GFP included as a reporter. 
The solid curves represent Hill functions fit to the mean data points. 
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Effects of PTX pretreatment on 5-HT1A and m2 receptor coupled GIRK 
currents 
Both 5-HT1A receptors and m2 receptors are capable of coupling to all 
PTX-sensitive Gαi/o subunits, and coupling in CHO-K1 cells is reportedly limited 
to endogenous expression of Gαi2 and Gαi3 subunits where Gαi2 protein levels 
predominate (Gαi2>>Gαi3 by 8:1) (Dell'Acqua et al., 1993; Raymond et al., 
1993). Pretreatment of cells with PTX (100 ng/ml) completely abolished the ACh-
evoked GIRK currents (n=5) and significantly reduced the 5-HT-evoked GIRK 
currents ~80% (PTX-treated 20±5 pA/pF, n=3; non-treated 94±14 pA/pF, n=8). 
Thus endogenous PTX-sensitive Gαi subunits mediate the coupling of m2 
receptors and 5-HT1A receptors to GIRK channels in CHO-K1 cells, although the 
residual 5-HT-evoked GIRK current following PTX pretreatment may reflect a 
small degree of ‘promiscuous’ 5-HT1A receptor coupling to PTX insensitive G 
proteins. 
 
Comparison of RGS3s and RGS4 effects on muscarinic m2 receptor-
coupled GIRK currents 
I next compared the modulatory effects of RGS3s and RGS4 on m2 
receptor activated Kir3.1/3.2a channels in relation to cells that were not 
transfected with exogenous RGS (control). Shown in Fig. 4.2, the activation and 
deactivation kinetics of ACh-evoked GIRK currents were accelerated by either 
RGS3s or RGS4 expression compared to the control cells. Kinetic analysis 
 49 
indicated RGS3s accelerated the GIRK deactivation time course somewhat 
greater than RGS4 (RGS3s τdeact=0.75±0.04 s, n=8; RGS4 τdeact=1.32±G0.11 s, 
n=5), although the effects of RGS3s on the GIRK activation kinetics were 
equivalent to RGS4 (Fig. 4.2C). The most striking difference between RGS3s 
and RGS4 was a significant reduction of GIRK current amplitude (~45% 
decrease at 100 µM) and a 6-fold shift in the ACh dose-response curve 
associated with RGS3s expression (Fig. 3.2D,E). With RGS3s, the Ach EC50 was 
5.1±0.6 µM (n=8) compared to 0.9±0.2 µM (n=10) for control cells. By 
comparison, RGS4 did not significantly affect the maximal GIRK current density 
as observed previously in Xenopus oocytes (Doupnik et al., 1997), and caused a 
smaller shift in the ACh EC50 value (2.0±0.5 µM, n=6) from the control group (Fig. 
4.2D,E). Since the ACh dose-response curve with RGS3s expression did not 
demonstrate saturation (Fig. 4.2D), GIRK current responses to 100 µM, 1 mM, 
and 10 mM ACh were also compared in a separate set of cells (n=9). These 
experiments confirmed that 100 µM Ach was indeed a saturating concentration, 
as maximal GIRK responses to 1 mM (95±2%) and 10 mM Ach (95±2%) were 
not significantly different than 100 µM ACh (93±2%). Altogether these findings 
indicate RGS3s and RGS4 both accelerate GIRK channel gating kinetics, but 
differentially affect steady-state m2 receptor-GIRK channel coupling properties. 
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Figure 4.2. Comparative effects of RGS3s versus RGS4 on muscarinic m2 
receptor-coupled Kir3.1/Kir3.2a channels expressed in CHO-K1 cells. (A) 
Representative ACh-activated GIRK currents elicited from three separate 
expression conditions; either without exogenous RGS expression (control 
traces), with exogenous RGS4 expression (RGS4 traces), or with exogenous 
RGS3s expression (RGS3s traces). GIRK currents evoked by a range of ACh 
concentrations for each cell are superimposed for comparison after baseline 
adjustment of the holding current immediately preceding each Ach application. 
ACh applications were 15 s in duration and separated by a ~1 min washout 
period. (B) Deactivation kinetics of RGS-accelerated GIRK currents. Upper 
panel: deactivation time constants (τdeact) derived from control (filled bar), RGS3s 
(grey bar), and RGS4 (open bar) groups following 10 µM ACh-evoked GIRK 
currents. Lower panel: comparison of tdeact values following three different ACh 
concentrations with either RGS3s (grey bars) or RGS4 (open bars) expression. 
Data are the mean±SE where * indicates P<0.05. (C) Activation kinetics of RGS-
accelerated GIRK currents. Comparison of activation time constants (τact) derived 
from control (filled bar), RGS3s (grey bar), and RGS4 (open bar) groups with 
increasing ACh concentrations. (D) ACh dose-response relations for control 
(filled squares), RGS3s (grey triangles), and RGS4 (open circles) groups. GIRK 
currents were normalized to cell membrane capacitance and expressed as a 
current density (pA/pF) for group comparisons. (E) Normalized ACh dose-
response curves from data presented in (D). GIRK current amplitudes were 
normalized to the maximal amplitude recorded from each cell (100 µM ACh) and 
fit with a Hill function to derive EC50 values and Hill coefficients. 
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Comparison of RGS3s and RGS4 effects on serotonin 1A receptor-coupled 
GIRK currents 
I next examined the effects of RGS3s and RGS4 on 5-HT1A-coupled GIRK 
currents to determine whether the different effects of RGS3s and RGS4 
observed with m2 receptor coupling were similarly conferred with 5-HT1A 
receptors. Shown in Fig. 4.3, co-expression of either RGS3s or RGS4 
significantly accelerated the activation and deactivation time course of 5-HT-
activated GIRK currents. Kinetic analysis of both the GIRK activation and 
deactivation time course indicated the accelerating effects of RGS3s and RGS4 
were not significantly different from each other (Fig. 4.3B,C). Interestingly, neither 
RGS3s nor RGS4 affected the maximal GIRK current density although both 
appeared to have subtle effects that were not statistically significant (Fig. 4.3D). 
Similar to m2 receptor coupling, RGS3s significantly shifted the 5-HT dose-
response curve yet RGS4 did not. For RGS3s, the 5-HT EC50 was 128±36 nM 
(n=5) compared to 30±9 nM (n=4) for the control cells and 48±6 nM (n=9) with 
RGS4 expression. Thus RGS3s, in contrast to RGS4, displays GPCR 
dependence in that it dramatically reduces steady-state m2 receptor-activated 
GIRK currents but not 5-HT1A receptor-coupled currents. 
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Figure 4.3. Comparative effects of RGS3s versus RGS4 on serotonin 1A (5-
HT1A) receptor-coupled Kir3.1/Kir3.2a channels expressed in CHO-K1 cells. (A) 
Representative 5-HT-activated GIRK currents elicited from three separate cell 
conditions, either without exogenous RGS expression (control traces), with 
exogenous RGS4 expression (RGS4 traces), or with exogenous RGS3s 
expression (RGS3s traces). GIRK currents evoked by a range of 5-HT 
concentrations for each cell were superimposed for comparison after baseline 
adjustment of the holding current immediately preceding each agonist 
application. 5-HT applications were 15 s in duration and separated by a ~1 min 
washout period. (B) Deactivation kinetics of RGS-accelerated GIRK currents. 
Upper panel: deactivation time constants (τdeact) derived from control (filled bar), 
RGS3s (grey bar), and RGS4 (open bar) groups following 10 µM 5-HT-evoked 
GIRK currents. Lower panel: comparison of τdeact values following three different 
5-HT concentrations with either RGS3s (grey bars) or RGS4 (open bars) 
expression. Data are the mean±SE where * indicates P<0.05. (C) Activation 
kinetics of RGS-accelerated GIRK currents. Comparison of activation time 
constants (τact) derived from control (filled bar), RGS3s (grey bar), and RGS4 
(open bar) groups with increasing 5-HT concentrations. (D) 5-HT dose-response 
relations for control (filled squares), RGS3s (grey triangles), and RGS4 (open 
circles) groups. GIRK currents were normalized to cell membrane capacitance 
and expressed as a current density (pA/pF) for group comparisons. (E) 
Normalized 5-HT dose-response curves from data presented in (D). GIRK 
current amplitudes were normalized to the maximal amplitude recorded from 
each cell (10 µM 5-HT) and fit with a Hill function to derive EC50 values and Hill 
coefficients. 
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Effects of RGS3s and RGS4 on basal GIRK channel activity 
I also analyzed the effects of RGS3s and RGS4 on receptor-independent 
basal GIRK current amplitudes as reflected in the holding currents in 25 mM K+ 
solution. Previous reports indicate RGS3 (original 519 a.a. isoform) and RGS4 
cause a significant increase in basal GIRK current activity when expressed in 
either CHO or HEK293 cells by apparently increasing the availability of free Gβγ 
subunits via RGS sequestration of Gα subunits (Bunemann and Hosey, 1998). 
This finding is in contrast to observations in the oocyte expression system, where 
RGS3 and RGS4 reduce IK,basal amplitudes by apparently shifting the equilibrium 
of Gα subunits towards their GDP-bound state due to RGS-enhanced GTP 
hydrolysis and effectively sequestering free Gβγ dimers that cause basal GIRK 
channel activity (Doupnik et al., 1997). In the CHO-K1 experiments reported 
here, expression of Kir3.1/Kir3.2a channels significantly increased the IK,basal 
amplitude compared to nontransfected CHO-K1 cells (Table 4.1), thus 
demonstrating a significant level of receptor-independent ‘basal’ GIRK channel 
activity in the absence of exogenous RGS expression. Comparison of IK,basal 
amplitudes from the control groups (RGS-) with co-expression of either RGS3s or 
RGS4 did not reveal a significant difference with either m2 receptor or 5-HT1A 
receptor expression (Table 4.1). Thus the effects reported by (Bunemann and 
Hosey, 1998) may result from significantly higher RGS protein levels produced 
with their transfection methods, since expression conditions that elevate RGS4 
 56 
levels in oocytes has also been reported to increase basal GIRK channel activity 
(Keren-Raifman et al., 2001) 
 
 
Table 4.1 Effects of RGS3s and RGS4 on basal GIRK channel activity in CHO-
K1 cells 
 
 
 
 
 Ik,basal (pA/pF)1 
 Control PTX-treated + RGS3s + RGS4 
Non-transfected 
CHO-K1 cells 
-10 ± 4 
(n=6) 
- - - 
Muscarinic m2 
receptor + 
Kir3.1/Kir3.2a 
-130 ± 17 
(n=10) 
-91 ± 16 
(n=5) 
-162 ± 26 
(n=8) 
-135 ± 23 
(n=6) 
Serotonin 1A 
receptor + 
Kir3.1/Kir3.2a 
-84 ± 23 
(n=11) 
-106 ± 21 
(n=3) 
-120 ± 31 
(n=5) 
-89 ± 10 
(n=11) 
 
 
1
 Data are resting membrane currents in 25 mM K+ at a holding potential of -100mV divided by 
the cell membrane capacitance 
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Effects of RGS3s and RGS4 on acute desensitization of GIRK currents 
In the absence of RGS co-expression, GIRK currents modestly 
desensitize during the short 15 s agonist application period (<10% of their 
amplitude). Co-expression of RGS4 causes a significant increase in the rate of 
‘acute’ desensitization which is attributable to the accelerated rate of signal 
termination during sustained receptor activation (Chuang et al., 1998; Doupnik et 
al., 1997). Shown in Fig. 4.4, comparisons of the extent of acute desensitization 
with RGS3s versus RGS4 expression during the 15 s agonist application period 
indicate equivalent effects on both IK,5-HT and IK,ACh. These findings are consistent 
with the rate of acute GIRK current desensitization being closely correlated with 
Gα GTPase activity and best reflected in the GIRK deactivation rates (Chuang et 
al., 1998; Leaney et al., 2004). As shown earlier for RGS3s and RGS4 (Figs. 4.2 
and 4.3), both RGS proteins accelerate GIRK deactivation rates to a similar 
degree. 
 58 
Figure 4.4. Acute GIRK current desensitization associated with different GPCR-
RGS coupling conditions. (A) Comparative effects of RGS3s (red trace) and 
RGS4 (blue trace) on acute desensitization of 5-HT1A receptor-activated GIRK 
currents without exogenous RGS expression (control, black trace). Peak 
amplitudes of the superimposed recordings were normalized for kinetic 
comparisons. Right panel: the percent desensitization was quantified by 
measuring the percent decline in the peak GIRK current amplitude measured at 
the end of the 15 s application period, as denoted by the application ‘‘window’’ 
(dotted box in left panel). Data are the mean±SE where * indicates a P<0.05 for 
comparisons between the control and RGS groups. (B) Comparative effects of 
RGS3s (red trace) and RGS4 (blue trace) on acute desensitization of muscarinic 
m2 receptor-activated GIRK currents without exogenous RGS expression 
(control, black trace). Right panel: quantification of acute GIRK desensitization 
was determined as described in (A). 
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DISCUSSION 
 
The goal of this study was to evaluate the modulatory effects of a recently 
identified ‘short’ RGS3 isoform on neuronal GIRK channels activated by different 
GPCRs in a mammalian cell expression system (CHO-K1 cells). The RGS3s 
mRNA transcript is abundant in mouse brain and heart (Reif and Cyster, 2000) 
and therefore may modulate GPCR regulation of neuronal and cardiac cell 
excitability. The effects of RGS3s were assessed in comparison to the closely 
related and previously studied RGS4 protein (Doupnik et al., 1997; Zhang et al., 
2002) that is co-expressed with RGS3 in individual neurons and atrial 
cardiomyocytes (Doupnik et al., 2004; Doupnik et al., 2001). The major finding of 
my experiments is that RGS3s modulates GIRK channels in a GPCR-dependent 
manner, whereas RGS4 modulated GIRK channels similarly for both of the 
GPCRs studied. RGS3s significantly reduced GIRK current amplitudes with m2 
receptor coupling and shifted the steady-state agonist dose-response relations, 
whereas RGS4 affected m2 receptor-activated GIRK currents similar to that 
observed with 5-HT1A receptors. These results may indicate RGS3s has distinct 
interactions with muscarinic m2 versus 5-HT1A receptor complexes, whereas 
RGS4 interacts similarly with both GPCR-GIRK channel complexes. There are 
several possible RGS-affected cellular processes that may contribute toward the 
modulatory differences that we have identified and are briefly discussed below.  
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GTPase accelerating activity of RGS proteins 
The GTPase accelerating activity of RGS proteins is mediated by direct 
interactions between the RGS domain and the Gα subunit (Ross and Wilkie, 
2000), and differences in RGS modulation of GIRK channels can reflect 
differences in RGS-Gα subunit selectivity (Doupnik et al., 1997; Zhang et al., 
2002). Although RGS3 and RGS4 both interact with Gαi/o and Gαq/11 subunits, 
RGS3 displays a higher affinity for Gα11 versus Gαi3 (Dulin et al., 1999; Neill et 
al., 1997) and RGS4 shows preferential interactions with Gαi/o subunits versus 
Gαq (Berman et al., 1996a). So for the Gαi-coupled receptors examined in my 
CHO-K1 experiments, these preferred RGS-Gα associations would generally 
favor greater accelerated GIRK deactivation rates with RGS4 compared to 
RGS3s. Yet to the contrary, these kinetic differences were not observed and in 
fact RGS3s accelerated the GIRK deactivation rate somewhat greater than 
RGS4. Thus differences in RGS3s versus RGS4 affinity for Gαi subunits are not 
apparent in the accelerated GIRK channel gating properties that reflect RGS-
enhanced GTPase accelerating activity and seem unlikely to explain my findings. 
 
 
 
RGS membrane association 
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Several members of the R4 subfamily, including RGS4, enhance 
membrane binding through a mechanism requiring their short N-terminal domain. 
These RGS proteins (RGS2, RGS4, RGS5, RGS8, RGS16, RGS18) possess N-
terminal palmitoylated cysteine residues and a conserved basic amphipathic α-
helix that confers membrane association and orientation that enhances their 
GTPase activating activity (Bernstein et al., 2000; Chen et al., 1999; Heximer et 
al., 2001; Saitoh et al., 2001; Tu et al., 2001). The RGS4 N-terminus also 
contains a ubiquitin degradation signal (Davydov and Varshavsky, 2000). Yet for 
both RGS4 and RGS8, deleting the N-terminal domain does not significantly 
affect RGS-accelerated activation and deactivation kinetics for GPCR-activated 
GIRK channels expressed in Xenopus oocytes, indicating RGS domain-Gα 
interactions are sufficient for these kinetic effects (Inanobe et al., 2001; Saitoh et 
al., 2001). However, deleting the RGS8 N-terminus does reduce acute 
desensitization during dopamine D2 receptor GIRK channel activation (Saitoh et 
al., 2001) which is attributable to RGS-enhanced GTPase activity (Chuang et al., 
1998). Remarkably, a ‘short’ RGS8 splice variant (RGS8s) differing only by the 
first 7-9 N-terminal residues shows diminished effects on GIRK activation and 
deactivation kinetics and altered selectivity for Gq-coupled receptor signaling 
(Saitoh et al., 2002). Furthermore, overexpression of the RGS8 N-terminal 
domain (1-5 a.a.) in rat sympathetic neurons dramatically accelerates α2-
adrenergic receptor activation of heterologously expressed GIRK channels, 
supporting an important role of the RGS8 N-terminus in facilitating receptor-GIRK 
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channel coupling (Jeong and Ikeda, 2001). In my comparison of RGS3s and 
RGS4 on GIRK kinetics reported here, despite their divergent N-terminal 
sequences, both displayed similar accelerating effects on GIRK activation and 
deactivation kinetics and equivalent effects on acute desensitization of receptor-
activated GIRK currents. Therefore, apparently, differences in RGS3s and RGS4 
N-terminal domains do not confer obvious kinetic differences in receptor-
dependent GIRK channel gating, despite their differential effects on receptor-
dependent steady-state gating properties.  
 
RGS-mediated translocation of GPCRs 
RGS4 is predominantly a cytosolic protein recruited to membranes by 
interactions with G protein subunits (Druey et al., 1998). RGS-specific 
translocation from the cytosol to the plasma membrane involves direct 
interactions with the GPCR complex and is determined in part by the relative 
affinity of the RGS-Gα subunit interaction (Masuho et al., 2004; Roy et al., 2003). 
It remains unclear whether cytosolic RGS proteins can incorporate into mature 
GPCR-GIRK channel complexes already located at the plasma membrane, or 
whether they co-assemble within the GPCR-GIRK channel complexes 
synthesized and assembled within the endoplasmic reticulum and Golgi 
apparatus (Lavine et al., 2002). Current evidence, however, clearly indicate 
RGS4 facilitates trafficking and recruitment of G proteins (Chuang et al., 1998) 
and m2 receptore Gαi2 complexes (Roy et al., 2003) from intracellular pools to 
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the plasma membrane, and thereby increases the density of functional receptors 
at the plasma membrane. For RGS8, deletion of the N-terminal domain (∆N-
RGS8) prevents G protein-induced subcellular translocation of ∆N-RGS8 to the 
plasma membrane (Saitoh et al., 2001). Similarly, translocation of the original 
RGS3 isoform from the cytosol to the plasma membrane also occurs but in an 
agonist- and Ca2+-dependent manner (Dulin et al., 1999). The Ca2+- dependent 
translocation of RGS3 was recently shown to be mediated by Ca2+ binding to an 
EF-hand motif located in the N-terminus of RGS3, which is not present in the 
shorter N-terminus of RGS3s (Tosetti et al., 2003). Together, these findings 
suggest RGS4 may translocate m2 receptor/Gαi complexes to the plasma 
membrane more effectively than RGS3s, due either to a lower RGS3s-Gαi 
affinity and/or a reduced efficacy of the RGS3s N-terminal domain in the 
translocation process. The consequence in either case would be a lower cell 
surface concentration of receptors with RGS3s expression, which is consistent 
with the reduced GIRK current responses and rightward shift in the ACh dose 
response curve observed with RGS3s expression. What is puzzling with this 
working hypothesis is why the RGS3s effect on steady-state receptor-dependent 
GIRK activation properties are more prominent for m2 receptors and less so for 
5-HT1A receptor complexes. 
 
 
Direct RGS-GPCR interactions 
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Similar to my observations reported here, different R4 RGS proteins 
exhibit GPCR-selective modulation of Gq/11-coupled (Wang et al., 2002; Xu et 
al., 1999) and other Gi/o-coupled signaling pathways (Ghavami et al., 2004). 
Moreover, the N-terminal domains of RGS3, RGS4, and RGS8 have been shown 
to affect the selective regulation among Gq/11-coupled receptors (Chatterjee et 
al., 1997; Saitoh et al., 2002; Zeng et al., 1998). Recently, the N-terminus of 
RGS2 was shown to have direct and selective interactions with the 3rd 
intracellular (i3) loop of Gq/11-coupled muscarinic receptors in vitro (Bernstein et 
al., 2004). Full-length RGS4 also interacts with the i3 loop of Gq/11-coupled 
muscarinic m1 and m5 receptors, but similar to RGS2, does not interact with the 
i3 loops of Gi/o-coupled m2 or m4 receptors (Bernstein et al., 2004). Thus direct 
interaction of RGS4 with the m2 receptor remains to be resolved, yet apparently 
does not involve interactions with the i3 loop. Given the divergent nature of the 
RGS3s N-terminal domain compared to RGS4, differential interactions of the 
RGS3s N-terminus with GPCRs seems plausible and could thereby affect the 
efficacy of receptor translocation to the plasma membrane and/or G protein 
activation in a GPCR-selective manner. The intrinsic G protein coupling 
properties of different GPCRs may also impact RGS interactions within the 
signaling complex. In the absence of overexpressed RGS proteins in CHO-K1 
cells, GIRK channels activated by m2 receptors and 5-HT1A receptors displayed 
significantly different agonist potencies with 5-HT being ~30-fold more potent 
than Ach (cf. Fig. 3.1). Differences in receptor expression, cell surface density, 
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and receptor translocation (i.e. 5-HT1A>m2 receptors) are all possible 
contributors to this observed difference as discussed above. The 5-HT1A 
receptor-coupled GIRK channels also displayed a PTX-insensitive component 
that may reflect promiscuous G protein coupling or coupling of residual Gαi 
subunits (not ADP-ribosylated) due to a higher coupling affinity. Reconstitution 
experiments comparing GPCR-Gαi binding affinities recently found agonist-
bound 5-HT1A receptors to have a 12-fold higher affinity for Gαi1(GDP)βγ 
compared to agonist-bound m2 receptors (Slessareva et al., 2003), indicating 
agonist-activated 5-HT1A receptors have an intrinsically higher efficacy for 
Gαi(GDP)βγ coupling compared to muscarinic m2 receptors. GPCR differences 
in intrinsic G protein coupling (i.e. precoupling) and the influence of associated 
RGS proteins are important considerations for future mechanistic investigations 
(Shea and Linderman, 1997). From our results described here, RGS3s and 
RGS4 could produce equivalent modulatory effects on 5-HT1A receptor-coupled 
GIRK channels due to a higher degree of G protein precoupling compared to m2 
receptors (Zhang et al., 2002). 
In summary, I compared the functional properties of the RGS3s isoform 
and RGS4 due to their expression in brain and heart (Kehrl et al., 2002; Reif and 
Cyster, 2000) and in native GIRK-expressing neurons and atrial myocytes 
(Doupnik et al., 2004; Doupnik et al., 2001). The GPCR dependent effects of 
RGS3s observed on neuronal GIRK channel function raise new questions 
regarding RGS-dependent modulation of GPCR-GIRK channel complexes. 
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To test if there is a selective interection among RGS-GIRK-GPCR 
complexes I next generated several RGS chimeras and deletion constructs, 
epitope tagged them, and by co-immunoprecipitation detected the possible 
interactions. 
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CHAPTER 5 
 
RGS4 DIRECTLY ASSOCIATES WITH MULTIPLE GPCR-KIR3  
CHANNEL SIGNALING COMPLEXES  
 
INTRODUCTION 
 
RGS4, a member of the “Regulators of G protein Signaling” gene family 
(Hollinger and Hepler, 2002; Ross and Wilkie, 2000), is abundantly expressed in 
the mammalian brain and peripheral nervous system (Druey et al., 1996; Gold et 
al., 1997; Koelle and Horvitz, 1996). Functionally, RGS4 augments the GTPase 
activity of Gi/o and Gq/11 proteins and accelerates the termination of G protein-
coupled receptor (GPCR) signaling (Berman et al., 1996b; Hepler et al., 1997; 
Mukhopadhyay and Ross, 1999; Watson et al., 1996). Genetic linkage and 
association analysis has identified the human RGS4 gene as a major 
susceptibility locus (chromosome 1q21-q22) for schizophrenia (Brzustowicz et 
al., 2000; Chowdari et al., 2002), where gene profiling studies have shown RGS4 
expression to be the most significantly reduced gene in the prefrontal cortex of 
schizophrenic subjects (Mirnics et al., 2001). These findings, together with the 
potential role of RGS4 in regulating several neurotransmitter systems known to 
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affect symptoms of schizophrenia (hallucinations, delusions, and depression), 
implicate RGS4 in the etiology of schizophrenia (Harrison and Weinberger, 
2005). Decreased RGS4 levels are also reported to correlate with the reduced 
cholinergic signaling found in Alzheimer’s disease (Muma et al., 2003). 
Aside from its potential role in neurological disease and disorders, RGS4 
is a highly regulated modulator that provides adaptive capabilities during various 
levels of cell signaling (Chidiac and Roy, 2003). At the transcriptional level, brain 
RGS4 mRNA levels are dynamically regulated by neurotransmitter activation of 
different GPCRs (Geurts et al., 2002; Geurts et al., 2003; Taymans et al., 2003), 
several drugs of abuse (cocaine, morphine, and amphetamines) (Bishop et al., 
2002; Garnier et al., 2003; Gold et al., 2003), stress and glucocorticoids (Ni et al., 
1999), and electroconvulsive seizures (Gold et al., 2002). At the post-
translational level, RGS4 protein is rapidly degraded via the ubiquitin-dependent 
N-end rule pathway, a process initiated by arginylation of Cys2 by arginyl-
transferases (Davydov and Varshavsky, 2000; Lee et al., 2005) and tightly 
coupled to the oxidative environment (Hu et al., 2005). Together these findings 
illustrate the multiple layers of regulation that determine the RGS4 protein 
concentration level that modulates Gi/o and Gq/11 signaling in the brain. 
One of the key effectors for Gi/o and Gq/11–coupled receptors that 
modulates neuronal excitability is the G protein-gated inwardly rectifying K+ 
(Kir3/GIRK) channel (Stanfield et al., 2002; Yamada et al., 1998). Kir3 channels 
in hippocampal neurons are localized to dendrites, dendritic spines, and the cell 
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soma (Drake et al., 1997) and thus well positioned for suppressing excitation 
following activation by pertussis toxin (PTX)-sensitive Gi/o-coupled receptors as 
evidenced in seizure-prone Kir3.2 knockout mice (Luscher et al., 1997; Signorini 
et al., 1997). In contrast to activation by Gi/o–coupled receptors, Kir3 channels 
are inhibited by PTX-insensitive Gq/11-coupled receptor signaling causing 
enhanced neuronal excitability (Nakajima et al., 1988). Kir3 channels can form 
stable macromolecular signaling complexes containing Gi/o– or Gs-coupled 
receptors (Lavine et al., 2002), heterotrimeric G proteins (Clancy et al., 2005; 
Huang et al., 1995; Ivanina et al., 2004; Krapivinsky et al., 1995b), and multiple 
kinases and phosphatases (Nikolov and Ivanova-Nikolova, 2004). Since RGS4 
significantly accelerates both the activation and deactivation time course for Gi/o-
coupled receptor-activated Kir3 channel currents without compromising current 
amplitude (Doupnik et al., 1997), it has been questioned whether RGS4 directly 
binds to GPCR-Kir3 channel complexes as a means of efficacious modulation 
and targeting specificity (Zhang et al., 2002). It is shown here that RGS4 directly 
interacts with several GPCR-Kir3 channel complexes comprised of either Gi/o or 
Gq/11-coupled receptors expressed in CHO-K1 cells. RGS4 coupling is mediated 
through interactions with the GPCR versus the Kir3 channel, and displays 
specificity since a closely related RGS homolog (RGS3s) (Jaen and Doupnik, 
2005; Reif and Cyster, 2000) does not interact with any of the GPCR-Kir3 
channel complexes tested.  
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RESULTS 
 
RGS4 and RGS3s protein expression in CHO-K1 cells.  
To determine whether RGS4 or RGS3s directly associate with GPCR-Kir3 
channel complexes I co-expressed N-terminal HA-tagged m2 receptors, C-
terminal MYC-tagged Kir3.1/Kir3.2a channels, with and without C-terminal FLAG-
tagged RGS3s or RGS4, in CHO-K1 cells. The HA-m2 receptor or the Kir3.1-
MYC subunit was then immunoprecipitated and probed for co-precipitating 
proteins by western blot analysis. Initial western blot analysis of cell lysates 
reaffirmed previous findings (Krumins et al., 2004) indicating RGS4 protein levels 
are low and often undetectable, and significantly less than RGS3s (Figure 5.1A). 
This has been attributed to the rapid degradation of RGS4 via the 
ubiquitin/proteasome-dependent N-end rule pathway initiated by arginylation of 
RGS4 at Cys2 (Davydov and Varshavsky, 2000; Lee et al., 2005). RGS3s 
notably lacks this N-terminal cysteine residue. I therefore also compared protein 
levels of the degradation-resistant RGS4(C2V) mutant (Davydov and Varshavsky, 
2000). As shown in Figure 5.1B, the level of RGS4(C2V) protein in the cell lysate 
was significantly greater than wildtype RGS4 and more comparable to the protein 
levels observed with RGS3s expression. Both RGS3s-FLAG (23.5 kDa) and 
RGS4(C2V)-FLAG (24.25 kDa) migrated near their calculated molecular weights 
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and were often accompanied by a slightly smaller band of lower intensity that 
may represent some degree of proteolysis or alternative translation initiation start 
site (Krumins et al., 2004). Given the similar and stable expression levels of 
RGS3s and RGS4(C2V), RGS4(C2V) was routinely used for immunodetection and 
for comparisons with RGS3s. 
Functional tests of co-expressed HA-tagged m2 receptors with Kir3.1-
MYC/Kir3.2a channels revealed ACh-elicited inwardly rectifying K+ currents were 
indistinguishable from those produced by their untagged counterparts reported 
previously (Jaen and Doupnik, 2005). Comparative analysis of the modulatory 
effects of FLAG-tagged RGS3s, RGS4, and RGS4(C2V) on the kinetics of IK,ACh 
activation and deactivation indicated all three RGS proteins accelerated Kir3 
channel gating properties to similar extents (Figure 5.1D,E). This was somewhat 
unexpected given the large difference in protein expression between RGS4 and 
RGS4(C2V), and suggests RGS4 protein levels (significantly lower than RGS3s 
and RGS4(C2V)) are saturating with regards to functional Kir3 channel 
modulation. Also consistent with my previous study (Jaen and Doupnik, 2005), 
RGS3s-FLAG caused a significant rightward shift in the ACh dose response 
relation (Figure 5.1F) and reduced peak IK,ACh amplitudes by ~50% (data not 
shown). 
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Figure 5.1. RGS3s, RGS4, and the degradation-resistant RGS4(C2V) mutant are 
differentially expressed in CHO-K1 cells, yet similarly affect muscarinic m2 
receptor-activated Kir3 channel current kinetics. (A & B) Western blot analysis of 
C-terminal FLAG-tagged RGS3s, RGS4, and RGS4(C2V) protein levels in 
transfected CHO-K1 cell lysates. Cells for each RGS group were co-transfected 
with the HA-tagged m2 receptor, C-terminal MYC-tagged Kir3.1 subunit, and the 
Kir3.2a subunit (see Methods for details). Sample lanes were each loaded with 
20 µg of total protein. (C) Whole-cell recordings of ACh-activated Kir3 channel 
currents from CHO-K1 cells expressing either no RGS (black traces), RGS3s-
FLAG (red trace), RGS4-FLAG (blue trace), or RGS4(C2V)-FLAG (green trace). 
The peak currents have been normalized to compare the RGS-dependent effects 
on Kir3 channel gating kinetics during and after a 15 s application of 1 µM ACh. 
The current deflections before and during ACh application are responses to 
voltage ramps (-100 mV to +50 mV) used to monitor inward rectification. The 
holding membrane potential was -100 mV in all cases. (D & E) RGS3s-FLAG 
(red), RGS4-FLAG (blue), and RGS4(C2V)-FLAG (green) similarly accelerate the 
activation and deactivation time course for m2 receptor-activated Kir3 channel 
currents. Single exponential fits to the activation and deactivation time course 
were performed to derive the time constants, τact and τdeact, respectively. The 
ACh concentration-dependence of τact is shown for each RGS examined (panel 
F). The τdeact values are following the rapid washout of 1 µM ACh. Values are the 
mean±SEM (n=7-9). (F) ACh-dose response relations for ACh-evoked Kir3 
channel currents expressing either no RGS (black symbols), RGS3s-FLAG (red 
symbols), RGS4-FLAG (blue symbols), or RGS4(C2V)-FLAG (green symbols). 
Mean values were fit with a Hill function (solid curves) to compare EC50 values 
for each condition. 
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Differential RGS interaction with m2 receptor-Kir3 channel complexes. 
HA-tagged m2 receptor was immunoprecipitated and probed for co-
precipitating Kir3.1-MYC and RGS-FLAG by western blot analysis. Shown in 
Figure 5.2, Kir3.1-MYC readily co-precipitated with the muscarinic m2 receptor 
demonstrating the presence of stable m2 receptor-Kir3 channel complexes 
similar to that reported for other GPCRs (Lavine et al., 2002). Interestingly 
though, while RGS4(C2V) readily co-precipitated with the m2 receptor-Kir3 
channel complex, RGS3s did not. The apparent molecular weights of the 
immunoprecipitated proteins were consistent with predicted and previously 
reported values. The immunoprecipitated HA-m2 receptor migrated as two major 
bands, one molecular weight band that closely corresponded to the calculated 
molecular weight (52.81 kDa) and a higher band (70-75 kDa) that corresponds to 
glycosylated receptors (van Koppen and Nathanson, 1990). The co-precipitated 
Kir3.1-MYC subunit also migrated close to its calculated molecular weight (57.77 
kDa). 
I next questioned whether the availability Gi proteins might influence the 
coupling of RGS3s and RGS4 to m2 receptor-Kir3 channel complexes given 
potential limiting levels of endogenous Gi proteins present within the CHO-K1 
cells. To test this, I examined the effects of co-expressing the Gαi2 subunit on 
RGS co-precipitation with the m2 receptor-Kir3 channel complex. As shown in 
Figure 5.3, Gαi2 expression appeared to slightly enhance wildtype RGS4 protein 
levels and RGS4 was now detected as a co-precipitating protein with the m2 
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receptor-Kir3 channel complex. Yet similar to the previous experiments without 
Gαi2 expression, RGS3s again did not co-precipitate with the complex and 
RGS4(C2V) was readily detected (Figure 5.3). Levels of RGS3s and RGS4(C2V) 
protein in the cell lysates were roughly equivalent, indicating the lack of RGS3s 
association with the complex was not attributable to differences in protein 
availability. These experiments clearly demonstrate that RGS4 and RGS4(C2V) 
can form a stable interaction with m2 receptor-Kir3 channel complexes and that 
the closely related RGS3s isoform does not interact with the same complex. 
The m2 receptor-Kir3 channel complex could also be immunopreciptated 
via the Kir3.1-MYC channel subunit, where the co-precipitating m2 receptor was 
then detected by western blot (data not shown). Yet in this configuration, co-
expression of Gαi2 blocked immunoprecipitation of Kir3.1-MYC. I speculate that 
immunoprecipitation via the cytosolic C-terminal Kir3.1-MYC epitope may be 
perturbed by cytosolic G protein interactions that map to the Kir3 C-terminus 
(Clancy et al., 2005).   
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Figure 5.2. Selective association of RGS4 with muscarinic m2 receptor-Kir3 
channel complexes. HA-muscarinic m2 receptors were immunopreciptated from 
CHO-K1 cells co-expressing Kir3.1- MYC/Kir3.2a channels and either no RGS, 
RGS3s-FLAG, or RGS4(C2V)-FLAG. Coprecipitating Kir3.1-MYC and RGS-FLAG 
proteins were then probed by western blot analysis. Western blot of the level of 
RGS-FLAG protein present within each of the cell lysates is shown in the lower 
panel. Note that lane one (sham), which is a negative control, from CHO-K1 cells 
transfected only with empty vector shows no unspecific binding of proteins in the 
cell lysate to the agarose beads as well as any detection of co-
immunoprecipitation. However, in the cell lysate, FLAG antibody shows some 
unspecific binding to proteins that are present in all conditions even those without 
RGS-FLAG protein expressed; those proteins have higher molecular weight than 
the RGS-FLAG proteins. Nevertheless, looking at the appropriate molecular 
weight between 20-25 kDa, specific RGS-FLAG detection from the cell lysates 
can be observed only in the conditions that were transfected with RGS-FLAG 
proteins. 
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Figure 5.3. Effects of Gαi2 co-expression on RGS coupling to muscarinic m2 
receptor-Kir3 channel complexes. A Gαi2 expression vector (the PTX-insensitive 
Gαi2(C352G) mutant) was included in the CHO-K1 cell transfections as described 
in figure 5.2. Note both RGS4 and RGS4(C2V) coprecipitate with the muscarinic 
m2 receptor-Kir3 channel complex, whereas RGS3s does not.  
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Structural determinants of RGS4 binding to m2 receptor-Gαi2-Kir3 channel 
complexes. 
RGS3s and RGS4 share a high degree of sequence homology within their 
conserved RGS domain (indeed they are nearest neighbors at 76% similarity), 
yet have important differences in their N-terminal sequences (Figure 5.4A). The 
N-terminal domain of RGS4 (aa 1-57) contains two palmitoylation sites (Cys2, 
Cys12) (Srinivasa et al., 1998) and an amphipathic alpha-helix (a.a. 1-33) 
(Bernstein et al., 2000; Tu et al., 1999; Tu et al., 2001) that are both highly 
conserved among two other R4 RGS proteins, RGS5 and RGS16 (Chen et al., 
1999; Druey et al., 1999). The amphipathic alpha-helix of RGS4 is both 
necessary and sufficient for membrane association (Bernstein et al., 2000; 
Srinivasa et al., 1998) and is conserved in the RGS3s N-terminus (Figure 5.4A). 
Yet the RGS3s N-terminus lacks the two palmitoylation sites (Cys2, Cys12) that 
help target RGS16 (and presumably RGS4 and RGS5) to cholesterol-rich 
membrane lipid rafts (Hiol et al., 2003) and enhances RGS GAP activity 
(Bernstein et al., 2000; Srinivasa et al., 1998; Tu et al., 1999; Tu et al., 2001). 
My initial hypothesis was that the RGS4 N-terminal domain was both 
necessary and sufficient for association of RGS4 with m2 receptor-Gαi2-Kir3 
channel complexes. To test this hypothesis, RGS4 deletion mutants and 
RGS3s/RGS4 chimeras (all FLAG-tagged at the C-terminus) were individually 
co-expressed along with the HA-m2 receptor, the Gαi2 subunit, and Kir3.1-
MYC/Kir3.2a channels (Figure 5.4B). The HA-m2 receptor was then 
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immunoprecipitated and co-precipitating RGS proteins probed by western blot. In 
support of my hypothesis, deleting the N-terminal domain of RGS4, RGS4(58-
205)-FLAG, resulted in the loss of association with the m2 receptor-Kir3 channel 
complex (Figure 5.4C) as expected with a loss of membrane association 
(Srinivasa et al., 1998). Yet interestingly, substituting the RGS3s N-terminal 
domain (a.a. 1-62) in place of the RGS4 N-terminal domain (R3s-R4-FLAG 
chimera) also resulted in the complete loss of association with the m2 receptor-
Kir3 channel complex (Figure 5.4C) suggesting palmitoylation of RGS4 Cys2 and 
Cys12 may also be necessary. Together these results clearly demonstrate that 
the RGS4 N-terminal domain is necessary for coupling to the signaling complex. 
Surprisingly, however, substituting the RGS4 N-terminal domain (with or 
without the C2V mutation) in place of the RGS3s N-terminal domain (R4-R3s-
FLAG chimera or R4(C2V)-R3s-FLAG chimera) conferred only very weak 
interactions with the m2 receptor-Kir3 channel complex, significantly less than 
RGS4(C2V) (Figure 5.4C). Thus the RGS4 N-terminal domain is clearly necessary 
for association with the m2 receptor-Kir3 channel complex, however the 
remaining RGS domain and/or C-terminus of RGS4 is also necessary for efficient 
high-affinity coupling. Note that the expression of these various RGS constructs 
had no effect on the level of m2 receptor-Kir3 channel coupling (Figure 5.4C), 
indicating assembly of m2 receptor-Kir3 channel complexes is not affected by 
RGS association. 
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Figure 5.4. Structural determinants of RGS4 association with muscarinic m2 
receptor-Kir3 channel complexes. (A) Amino acid sequence alignment of the 
mouse RGS3 ‘short’ isoform and rat RGS4. Asterisks denote sites of sequence 
identity and green residues denote the highly conserved RGS domain. The N-
terminal amphipathic alpha helical domains are boxed and the conserved basic 
residues highlighted in red, and the palmitoylated RGS4 C2, C12 residues 
highlighted in orange. The arrowhead denotes the site for RGS deletions and 
junction site for RGS chimeras. (B) Schematic diagram illustrating C-terminal 
FLAG-tagged RGS proteins constructed and tested for co-precipitation with 
muscarinic m2 receptor-Kir3 channel complexes. RGS4 regions are in blue, 
RGS3s regions are in red. (C) The RGS4 N-terminal domain (a.a. 1-57) is 
necessary for RGS association with muscarinic m2 receptor-Kir3 channel 
complexes. Six different RGS-FLAG constructs were individually coexpressed 
with HA-muscarinic m2 receptors, the Gαi2(C352G) subunit, and Kir3.1-
MYC/Kir3.2a channels in CHO-K1 cells. The HA-m2 receptor was then 
immunoprecipitated and coprecipitating Kir3.1-MYC and RGS-FLAG proteins 
detected by western blot. RGS-FLAG present in the cell lysates are shown in the 
lower blot. Faint bands for RGS4(58-205)-FLAG (lane 2), the R4-R3s-FLAG (lane 
5), and R4(C2V)-R3s-FLAG chimera (lane 6) could be detected, yet none of the 
RGS constructs matched the level of coupling displayed by RGS4(C2V)-FLAG. 
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RGS4(C2V) associates with multiple GPCR-Kir3 channel complexes 
Kir3 channels are functionally coupled to a variety of Gi/o-coupled 
receptors in the nervous system and heart (Stanfield et al., 2002; Yamada et al., 
1998). To determine whether RGS3s and RGS4 selectively associate with 
different Gi/o-coupled receptors known to activate native Kir3 channels, I 
examined RGS and Kir3 channel co-precipitation with several different HA-
tagged GPCRs (serotonin 1A, adenosine A1, dopamine D2L, and LPA1 
receptors) co-expressed with either Gαi2 or GαoA. With Gαi2 expression, each 
GPCR tested (serotonin 1A, adenosine A1, and LPA1 receptors) co-precipitated 
Kir3.1-MYC/Kir3.2a channels (Figure 5.5 and Figure 5.6) and behaved just as the 
muscarinic m2 receptor (cf, Figure 5.3). Moreover, each GPCR-Kir3 channel 
complex demonstrated the same selectivity in associating with RGS4(C2V) but 
not RGS3s. Wildtype RGS4 coupling was not readily detectable as RGS4 
expression levels were significantly less than both RGS3s and RGS4(C2V).  
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Figure 5.5. RGS4(C2V) associates with multiple Gi-coupled receptor-Kir3 channel 
complexes. Three different HA-tagged GPCRs, the adenosine A1 receptor (3HA-
A1R), the serotonin 1A receptor (HA-5-HT1AR), and the lysophosphatidic acid 1 
receptor (HA-LPA1R), were expressed in CHO-K1 cells with Kir3.1-MYC/Kir3.2a 
channels, the Gαi2(C352G) subunit, and either no RGS, RGS3s-FLAG, RGS4-
FLAG, or RGS4(C2V)-FLAG. Each HA-tagged GPCR was then 
immunoprecipitated (IP) and co-precipitating (Co-IP) Kir3.1-MYC and RGS-FLAG 
proteins detected by western blot (WB). Kir3.1-MYC and RGS4(C2V)-FLAG co-
precipitated with each HA-GPCR. 
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Similarly with GαoA expression, each GPCR tested (serotonin 1A, 
adenosine A1, dopamine D2L, and LPA1 receptor) co-precipitated Kir3.1-
MYC/Kir3.2a channels and RGS4(C2V), but not RGS3s (Figure 5.6). Thus RGS3s 
does not directly interact with a variety of Gi/o-coupled receptors, whereas 
RGS4(C2V) coupling is rather promiscuous. 
It is worth noting that the immunoprecipitation levels of the different HA-
tagged GPCR proteins varied considerably, with m2 receptors and dopamine 
D2L receptors being markedly less than serotonin 1A, adenosine A1, or LPA1 
receptors (Figure 5.6). The underlying cause for these differences are not clear, 
and was not attributable to either the N-terminal HA tag (1X-HA versus 3X-HA) or 
the presence of the signal sequence. The differences apparently reflect distinct 
coding region differences that affect GPCR protein expression levels. The level 
of co-precipitating RGS4(C2V) did not correlate with the level of 
immunoprecipitated HA-GPCR, being somewhat constant for each expression 
condition and indicates the fraction of associated RGS4(C2V) differed for each 
GPCR. 
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Figure 5.6. RGS4(C2V) associates with multiple Go-coupled receptor-Kir3 
channel complexes. Effects of GoA subunit expression on RGS coupling to 
different GPCR-Kir3 channel complexes. Five different HA-tagged GPCRs, the 
muscarinic m2 receptor (HA-m2R), the serotonin 1A receptor (HA-5-HT1AR), the 
lysophosphatidic acid 1 receptor (HA-PA1R), the adenosine A1 receptor (3HA-
A1R), and the dopamine D2L (3HA-D2LR), were expressed in CHO-K1 cells with 
Kir3.1-MYC/Kir3.2a channels, the GαoA(C351G) subunit, and either RGS4(C2V)-
FLAG (left panel) or RGS3s-FLAG (right panel). Kir3.1-MYC and RGS4(C2V)-
FLAG co-precipitated with each HA-GPCR, whereas RGS3s-FLAG did not 
couple to any of the GPCR-Kir3 channel complexes. 
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Since both RGS3 and RGS4 are also effective GAPs for Gαq (Hepler et 
al., 1997; Scheschonka et al., 2000), I also tested whether RGS3s might 
associate with a GPCR known to couple selectively to Gαq subunits, namely the 
muscarinic m1 receptor. For these experiments I co-expressed Gαq and Kir3.1-
MYC/Kir3.2a channels, and tested in parallel three additional GPCRs that display 
varying degrees of Gq coupling for comparison (LPA1, serotonin 1A, and m2 
receptor). Interestingly, Kir3.1-MYC/Kir3.2a channels co-precipitated with the 
muscarinic m1 receptor indicating Gq-coupled receptors can also form stable 
complexes with Kir3 channels (Figure 5.7). As observed with the Gi/o-coupled 
receptors, RGS3s again failed to couple to the m1 receptor-Kir3 channel complex 
(or any of the other GPCR-Gαq-Kir3 channel complexes) whereas RGS4(C2V) 
directly interacted with the m1 receptor-Kir3 channel complex (Figure 5.7). Thus 
despite the functional effects of RGS3s on Kir3 channel gating kinetics (cf. Figure 
5.1), RGS3s does not directly couple to any of the GPCR-Kir3 channel 
complexes tested in my experiments. 
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Figure 5.7. Kir3 channels and RGS4(C2V) co-assemble with Gq-coupled 
receptors. Four different HA-tagged GPCRs, the muscarinic m2 receptor (HA-
m2R), the serotonin 1A receptor (HA-5-HT1AR), the lysophosphatidic acid 1 
receptor (HA-LPA1R), the muscarinic m1 receptor (3HA-m1R), were expressed in 
CHO-K1 cells with Kir3.1-MYC/Kir3.2a channels, the Gαq subunit, and either 
RGS4(C2V)-FLAG (panel A) or RGS3s-FLAG (panel B). Each HA-tagged GPCR 
was then immunoprecipitated (IP) and co-precipitating (Co-IP) Kir3.1-MYC and 
RGS-FLAG proteins detected by western blot (WB). Kir3.1-MYC and RGS4(C2V)-
FLAG co-precipitated with each HA-GPCR (panel A), whereas RGS3s-FLAG did 
not couple to any of the GPCR-Kir3 channel complexes (panel B). The RGS-
FLAG present in each of the cell lysates is shown in the lower blots. 
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RGS4(C2V) couples to GPCRs independent of co-assembled Kir3 channels  
The next question was whether RGS4(C2V) association with GPCR-Kir 
channel complexes was mediated via specific GPCR interactions, by direct Kir3 
channel interactions, or by interactions with both. To determine this I 1) co-
expressed several GPCRs with RGS4(C2V) in the absence of Kir3 channel 
expression, and 2) co-expressed RGS4(C2V) with Kir3.1-MYC/Kir3.2a channels in 
the absence of HA-GPCR expression. As shown in Figure 5.8A, 
immunoprecipitation of each HA-GPCR readily co-precipitated RGS4(C2V) in the 
absence of Kir3 channel expression. Thus the GPCR alone is sufficient, and the 
Kir3 channel not necessary for RGS4(C2V) coupling to GPCR complexes. Shown 
in Figure 5.8B, in the absence of HA-GPCR expression, immunoprecipitation of 
Kir3.1-MYC/Kir3.2a channels failed to co-precipitate RGS4(C2V). 
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Figure 5.8. RGS4(C2V) couples to GPCRs and not the Kir3 channel. (A) Six 
different HA-tagged GPCRs (the muscarinic m2 receptor (HA-m2R), the 
serotonin 1A receptor (HA-5-HT1AR), the lysophosphatidic acid 1 receptor (HA-
LPA1R), the adenosine A1 receptor (3HA-A1R), the dopamine D2L (3HA-D2LR), 
and the muscarinic m1 receptor (HAm1R), were expressed in CHO-K1 cells with 
RGS4(C2V)-FLAG in the absence of Kir3.1-MYC/Kir3.2a channel expression. 
Immunoprecipitation (IP) of each of the HA-GPCRs coprecipitated (Co-IP) 
RGS4(C2V)-FLAG as determined by western blot (WB) analysis. (B) Co-
expression of Kir3.1-MYC/Kir3.2a channels and RGS4(C2V)-FLAG in the absence 
of HA-GPCR. Immunoprecipitation of Kir3.1-MYC failed to co-precipitate 
RGS4(C2V)-FLAG as determined by western blot analysis. 
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Functional impact of direct RGS4 coupling to GPCR-Kir3 channel 
complexes 
RGS3s, RGS4, and RGS4(C2V) each accelerated the activation and 
deactivation gating kinetics of Kir3.1/Kir3.2 channels to equivalent extents in 
CHO-K1 cells despite differences in their physical coupling to m2 receptor-Kir3 
channel complexes (cf. Figure 5.1). Examination of the accelerating effects of 
each of the N-terminal deletion constructs (RGS4(58-205) and RGS3s(63-192)) and 
RGS chimeras (R3s-R4 chimera and R4-R3s chimera) on ACh-activated Kir3 
channel currents recorded from CHO-K1 cells also failed to identify any 
functional difference that might correlate with the differences in RGS precoupling 
to the signaling complex (data not shown). I therefore questioned whether direct 
RGS interaction with GPCR-Kir3 channel complexes in CHO-K1 cells was of no 
functional benefit due to saturating levels of RGS protein expression and high 
degree of RGS3s ‘collision coupling’. 
To control and vary the expression levels of RGS3s and RGS4, the 
Xenopus oocyte system was used because in that system protein expression 
levels can be incrementally increased by titrating the amount of injected cRNA 
(Zhang et al., 2002). Given the similar steady-state protein levels of RGS3s-
FLAG and the degradation-resistant RGS4(C2V)-FLAG mutant in CHO-K1 cells, 
those were the RGS proteins used in the oocyte system. Concentration-
dependent modulatory effects of these two RGS proteins on m2 receptor-
activated Kir3.1/Kir3.2a channels expressed in Xenopus oocytes were examined. 
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Shown in Figure 5.9, the amount of RGS3s-FLAG cRNA necessary to produce a 
maximal acceleration in the Kir3 channel deactivation rate (10 ng/oocyte), was 30 
times greater than the amount of RGS4(C2V)-FLAG cRNA necessary to produce 
an equivalent effect (0.3 ng/oocyte). The derived EC50 values similarily indicate 
there is a 30-fold greater potency for RGS4(C2V) (EC50, 0.12 ng cRNA/oocyte) 
versus RGS3s (EC50, 3.3 ng cRNA/oocyte). These results reveal the primary 
functional impact of direct RGS4 coupling is a greater potency in accelerating the 
gating kinetics of receptor-activated Kir3 channels through targeted association. 
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Figure 5.9. Differential potency of RGS3s and RGS4(C2V) in accelerating the 
deactivation kinetics of muscarinic m2 receptor-activated Kir3 channel currents in 
Xenopus oocytes. (A) ACh-activated Kir3 channel currents recorded from 
oocytes expressing the muscarinic m2 receptor, Kir3.1/Kir3.2a channel subunits, 
and either RGS3s-FLAG (red traces) or RGS4(C2V)-FLAG (green traces) at two 
different expression levels (1 and 10 ng cRNA/oocyte). Inward Kir3 channel 
currents were elicited by a 25 s application of 1 µM ACh, from a holding potential 
of -80 mV. Current amplitudes have been normalized to illustrate kinetic 
differences in the activation and deactivation time course. (B) Concentration-
dependent effects of RGS3s-FLAG (red symbols) and RGS4(C2V)-FLAG on Kir3 
channel deactivation kinetics. The deactivation time course following the rapid 
removal of 1 µM ACh was fit with a single exponential function to derive 
deactivation time constants. Separate groups of oocytes injected with increasing 
amounts of cRNA (0.03-10 ng/oocyte) encoding RGS3s-FLAG (red symbols) or 
RGS4(C2V)-FLAG (green symbols) were tested in parallel. Values represent the 
mean±SEM (n=8) from two separate batches of oocytes. Mean time constant 
values for RGS3s-FLAG (red symbols) and RGS4(C2V)-FLAG (green symbols) 
were fit with a modified Hill function to derive the effective concentration of cRNA 
(ng/oocyte) producing 50% of the maximal acceleration in current deactivation 
(EC50). 
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DISCUSSION 
 
RGS4(C2V) precouples to multiple GPCRs 
My findings reported here demonstrate a remarkable promiscuity in the 
association of RGS4(C2V) with several Gi/o and Gq/11-coupled receptors that 
assemble with Kir3 channels to form macromolecular signaling complexes. 
Critical to this observation was the utilization of the degradation-resistant 
RGS4(C2V) mutant that increased protein expression and enabled reliable 
detection of RGS4(C2V) in my co-immunoprecipitation assays. RGS4(C2V) 
demonstrated a strong interaction with each of the GPCRs tested, but did not 
directly interact with the Kir3 channel, indicating selectivity in association with 
different transmembrane proteins. A previous study had found recombinant GST-
RGS4 fusion protein to interact in vitro with Kir3 channels expressed in HEK293 
cells, suggesting a direct RGS4-Kir3 channel interaction (Fujita et al., 2000). In 
light of my findings, the GST-RGS4 interactions may have been with endogenous 
GPCRs co-assembled with the Kir3 channels expressed in HEK293 cells. 
Alternatively, RGS4 may have interactions with Kir3 channels that are not 
detected in our co-immunoprecipitation experiments, but more apparent using 
the recombinant RGS4 protein. The association of RGS4(C2V) to multiple Gi/o 
and Gq/11-coupled receptors independent of the Kir3 channel effector, suggests 
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precoupled RGS4-GPCR complexes are likely to participate in the G-protein-
dependent modulation of several other known ion channel effectors regulating 
neuronal excitability (e.g. Kir2 and Kir6 channels, KCNQ channels, TRP 
channels, and voltage-gated Ca2+ channels). 
 
Structural determinants of RGS4 coupling to GPCRs 
RGS4 was recently found to directly interact with the third intracellular loop 
(i3L) of muscarinic m1 and m5 receptors, but not the i3L of m2 receptors 
(Bernstein et al., 2004). My experiments showing RGS4(C2V) co-precipitates with 
muscarinic m1 receptors is therefore interpreted as a result, at least in part, of 
direct protein-protein interactions between RGS4(C2V) and the m1 receptor. The 
lack of RGS4 interactions with the i3L of m2 receptors (Bernstein et al., 2004) 
suggests other m2 receptor domains may also participate in direct receptor-
RGS4 coupling, or alternatively the coupling could be mediated indirectly via 
interactions with precoupled Gαi/o subunits or other proteins. Recent reports of 
RGS4 co-precipitating with µ- or δ-opioid receptors from periaqueductal gray 
membranes (Garzon et al., 2005) and involving direct interactions between 
RGS4 and the C-terminal domains of µ- or δ-opioid receptors (Georgoussi et al., 
2005) suggests RGS4 may also directly bind to the C-terminal domain of other 
GPCRs including the m2 receptor. 
The structural determinants of RGS4 that mediate association with GPCR-
Kir3 channel complexes support a critical role of the RGS4 N-terminal domain, 
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since deleting the N-terminus and substituting the RGS3s N-terminus (R3s/R4 
chimera) resulted in decoupling from the GPCR-Kir3 channel complex. Since the 
RGS4 N-terminus confer membrane association (Srinivasa et al., 1998) and 
contains two palmitoylation sites that are expected to facilitate targeting to 
membrane lipid rafts (Hiol et al., 2003) where GPCRs (Papoucheva et al., 2004), 
heterotrimeric G proteins (Moffett et al., 2000), and Kir3 channels localize 
(Delling et al., 2002), there are apparent cooperative and selective interactions 
involving the RGS4 N-terminus and the RGS4 RGS domain that together 
mediate the high affinity coupling. My findings are consistent with the model 
proposed by Wilkie and colleagues (Zeng et al., 1998), where the RGS4 N-
terminus directly interacts with the GPCR and the RGS domain interacts with the 
precoupled Gα subunit. Thus receptor-RGS4 association is expected to increase 
the degree of precoupled receptor-G protein complexes. Recent fluorescence 
resonance energy transfer (FRET) experiments  support a stable interaction 
between RGS proteins (RGS7 and RGS8) and Gα subunits within an agonist-
receptor-G-protein quaternary complex (Benians et al., 2005). Importantly, 
however, these experiments did not detect FRET between RGS8 and the GPCR, 
indicating the RGS-Gα FRET signals could be potentially derived via a collision-
coupled process. It will be important to extend our co-immunoprecipitation 
experiments to RGS8 and other members of the RGS protein family to identify 
RGS proteins that stably associate with different GPCRs, and identify those that 
do not. 
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Although I found no evidence for receptor-specific association of 
RGS4(C2V), wildtype RGS4 coupling was low or not detectable for each of the 
GPCRs tested. This may be in part due to the low RGS4 protein levels caused by 
the rapid degradation of RGS4 via the N-end rule pathway (Davydov and 
Varshavsky, 2000), or alternatively could reflect effects of Cys2 modifications on 
coupling to GPCRs. The RGS4 Cys2 residue is the target of palmitoylation 
(Srinivasa et al., 1998), arginylation (Davydov and Varshavsky, 2000), 
nitrosylation (Hu et al., 2005), and oxidation (Hu et al., 2005), where the 
RGS4(C2V) mutant would be insensitive to any negative effects of Cys2 
modifications on GPCR coupling. Future studies exploring the role of the RGS4 
Cys2 site and its modifications on the efficacy of specific GPCR coupling will be 
needed to resolve this fascinating possibility. 
 
Implications of RGS4 precoupling versus RGS3s collision-coupling 
My initial electrophysiological measures of RGS3s- versus RGS4-
dependent modulation of Kir3 currents in CHO-K1 cells did not reveal any 
functional advantage for precoupled RGS4 proteins versus uncoupled RGS3s. 
Yet RGS dosage experiments in Xenopus oocytes clearly demonstrated that 
RGS4(C2V) precoupling provides a 30-fold greater potency in Kir3 channel 
modulation versus uncoupled RGS3s. These findings illustrate the high level of 
RGS collision-coupling that occurs in the CHO-K1 expression experiments, a 
likely result of the high protein expression levels produced in this commonly used 
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mammalian expression system. Functional assays probing for RGS-GPCR 
coupling specificity using similar assay systems are likely biased for ‘false-
positives’ due to the high degree of RGS collision-coupling and the generally low 
selectivity of several RGS proteins towards Gi/o, Gq/11, and Gz subunits. 
Experimental protocols implementing RGS dosage in live cell assays should help 
resolve RGS selectivity in the modulation of specific GPCR signaling pathways. 
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CHAPTER 6 
 
CONCLUDING REMARKS 
 
The original purpose of this study was to characterize the specific RGS 
proteins that modulate endogenous neuronal GIRK channels. Initially I used CG 
neurons, a native cell type that endogenously expresses GIRK channels. In order 
to determine the endogenous RGS proteins that were likely to be involved in 
GIRK channel modulation, a RGS expression profile was performed. This work 
has shown that CG neurons can express at least 13 RGS genes. Comparison of 
RGS gene expression profiles from different native cell types (i.e. CG neurons vs 
cardiac myocytes) can give us an indication of which RGS proteins may be 
physiologically important for each cell type. 
It has been demonstrated that GIRK channels can form stable signaling 
complexes with GPCRs (Lavine et al., 2002), and multiple RGS proteins are 
expressed within single GIRK-expressing neurons and atrial myocytes (Doupnik 
et al., 2004; Doupnik et al., 2001; Gold et al., 1997). 
How are cells able to specifically activate a determined signaling 
pathway? 
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One way of signaling pathway specificity may come through selective 
interaction of RGS proteins with various GPCR-effector signaling complexes.  
To test this hypothesis I studied RGS3s and RGS4, two RGS’s whose 
mRNA levels are transcriptionally regulated in the nervous system during 
pathophysiologic conditions (Costigan et al., 2003). 
My findings demonstrate a tight coupling between RGS4 and several 
GPCRs that are central participants in normal and pathologically altered 
neuromodulation. Interaction among the different GPCRs-GIRK-RGS proteins 
seems to be very specific, since only RGS4 was able to co-immunoprecipitate 
with the GPCR-GIRK channel signaling complexes and RGS3s was not (Figure 
6.1).  
My results highlight the importance that selective RGS-GPCR interactions 
may have physiologically. The functional impact of RGS4(C2V) precoupled to the 
GPCR-Kir3 channel complex was a 30-fold greater potency in the acceleration of 
Kir3 channel gating kinetics, compared to the uncoupled (or collision coupled) 
RGS3s. This disparity in potency observed between RGS4(C2V) and RGS3s is 
probably due to the coupling of RGS4(C2V) to the GPCR-GIRK signaling 
complex. Further experiments in the oocyte system using the different chimeras 
and deletion constucts are needed to corroborate this hypothesis. 
Given the multiple mechanisms affecting RGS4 protein levels, it will be 
important to determine to what extent these changes in RGS4 concentration 
affect coupling to different GPCR signaling pathways. Recently, a mutation in an 
 108 
RGS protein, RGS9-1 that is involved in the rhodopsin signaling complex has 
been shown to be the cause of a disease (bradyopsia) in humans, a non-lethal 
condition characterized by an inability to resolve rapidly changing visual scenes 
(Nishiguchi et al., 2004). 
In summary, my findings demonstrate that RGS4, a highly regulated 
modulator and susceptibility gene for schizophrenia, is an integral component of 
multiple GPCR-Kir3 channel complexes affecting a wide range of 
neurotransmitter-mediated events in the nervous system. Acquired or inherited 
disruptions in RGS4-GPCR coupling may also be critical for a variety of 
neurological disorders that may include schizophrenia, depression, epilepsy, and 
drug addiction. Future experiments in native tissue are needed to detect the 
location and identification of the distinct RGS proteins involved in the coupling to 
the different GPCR-effector signaling complexes. Although my experiments have 
been performed in an heterologous system, the interactions reported here may 
be physiologically important for several reasons: 1) RGS4 has been reported to 
co-immunoprecipitate with µ- and δ-opioid receptors from periaqueductal gray 
membranes (Garzon et al., 2005), 2) the functional impact that precoupled RGS4 
has in contrast to uncoupled RGS3s in the Xenopus oocyte experiments once 
the protein concentration of both RGS was reduced and tritated 3) The 
precoupling is RGS protein specific, being only RGS4 able to associate to the 
different GPCR-GIRK channel complexes. 
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Figure 6.1. Differential coupling of RGS proteins to GPCR-GIRK channel 
signaling complexes. (A) RGS4 couples to GPCR-GIRK channel signaling 
complexes, interacting with the GPCR and not with the GIRK subunit. (B) RGS3s 
does not couple to the GPCR-GIRK channel signaling complexes. 
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